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ABSTRACT 
„Frozen Shoulder‟ is a term which describes a combination of shoulder pain and 
stiffness that causes sleep disturbance and marked disability, and which runs a 
prolonged course (Hanchard et al 2011). Physiotherapy has been advocated; 
however there is no robust evidence on the superiority of any one treatment 
modality (Callinan et al 2003). 
The aim of this study was to evaluate the effect of an exercise class compared 
to multimodal physiotherapy and a home exercise programme in patients with 
frozen shoulder. The objectives were to identify that clinical scores were 
effective at detecting change in the different treatment groups and to provide 
recommendations for the physiotherapeutic management of frozen shoulder. 
The study design was a randomised controlled trial with seventy five patients 
enrolled. The primary outcome measure was the Constant score, secondary 
outcome measures included the Oxford Shoulder Score (OSS), Hospital Anxiety 
and Depression Scale (HADS) and the short form 36 item health survey (SF-
36). A repeated measures one-way analysis of variance on the outcome data 
was conducted.  
Results from the Constant score and OSS indicate that at six weeks, six months 
and one year, an Exercise Class was more effective than Multimodal 
Physiotherapy or Home Exercises. The results from the HADS indicate that the 
Exercise Class was more effective than Multimodal Physiotherapy or Home 
Exercises at six weeks and six months. However, at one year Multimodal 
Physiotherapy was more effective than the Exercise Class and Home 
Exercises.  
This study provides an original contribution to knowledge in frozen shoulder and 
has important implications for enhancing clinical practice. The findings suggest 
that a hospital based exercise class produced a rapid recovery with a minimum 
number of visits to the hospital. Physiotherapy could also be considered to 
optimise speed of recovery of frozen shoulder. The Constant score, OSS and 
HADS are recommended in the management of frozen shoulder. Finally, GPs 
and physiotherapists require training in the clinical diagnostic accuracy of frozen 
shoulder. The need for further research in this area is emphasized. 
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Chapter 1 LITERATURE REVIEW 
 
1.1  SEARCH STRATEGY 
 
Literature searches using the computer based AMED, EMBASE, MEDLINE, 
CINAHL, Proquest, Biomed Central, Pubmed Central databases in addition to 
the Cochrane database were undertaken to identify relevant literature 
surrounding frozen shoulder. There were no limitations on the year of 
publication for any of the searches. The search strategy was repeated 
throughout the study and was aimed at retrieving references relating to frozen 
shoulder. Search terms used included „frozen shoulder, adhesive capsulitis, 
physiotherapy, physical therapy, shoulder outcome measures, shoulder pain, 
exercise classes, stretches, rehabilitation, exercise and compliance‟. In addition, 
the reference lists of articles identified through the above process were also 
searched to uncover any further relevant literature. Eligibility criterion was set as 
English language and the title and abstract fields were included in the search. 
There were 385 hits and 287 articles retrieved. Of the research papers retrieved 
50% of references were over ten years old.  
 
1.2 INTRODUCTION 
 
Frozen shoulder, or adhesive capsulitis, was defined in the seminal work of 
Reeves (1975), as a condition of uncertain aetiology characterised by the 
spontaneous onset of pain with significant restriction of both active and passive 
range of movement of the shoulder. Duplay (1872) was credited with the initial 
description of the painful and restricted shoulder. Codman first introduced the 
term frozen shoulder in 1934 and described it as “a condition difficult to define, 
difficult to treat and difficult to explain from the point of view of pathology” 
(Codman, 1934:254). In 1945, Neviaser coined the term „adhesive capsulitis‟ 
theorising that this pathology results from thickening and eventual contracture of 
the glenohumeral capsule to reflect his findings at surgery and autopsy, in 
patients treated for a painful stiff shoulder. Nobuhara (2003) has also reviewed 
the terminology surrounding frozen shoulder. The condition is known as 50s 
shoulder in Japan. According to an eighteenth-century source, Rigenshuran, 
defines 50s shoulder as “pain in the arm and joints which develops at about age 
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50 at times, but improves after a while without the administration of drugs” 
(Nobuhara, 2003:161). 
 
Frozen shoulder can be a primary or idiopathic problem or it may secondarily be 
associated with another systemic illness. Both primary and secondary frozen 
shoulders have similar clinical presentations but distinct precipitating factors 
(Stam 1994). Although there is undoubtedly dispute about the diagnostic 
terminology associated with frozen shoulder, an improved understanding of 
different pathological processes has led to most authors using similar 
definitions. 
 
A primary or „true‟ frozen shoulder occurs where there is no exogenous cause 
or pre-existing condition. It presents an idiopathic decreased range of 
movement in which no systemic diagnosis, precipitating shoulder condition or 
radiographic explanation can be found (Neviaser and Neviaser 1987; Kelly 
1993; Stam 1994). Secondary frozen shoulders are defined as those with a 
known intrinsic or extrinsic precursor, typically causative of shoulder pain and 
dysfunction that ultimately leads to global stiffness; e.g. diabetes, stroke, hypo 
or hyper thyrodism, rotator cuff disease, cardiac disease and in association with 
prolonged immobilisation or trauma (Lundberg 1969; Rizk et al 1983 and 
Bunker 1997). 
 
This study was investigating „primary‟ or „true‟ frozen shoulder. 
 
1.3 AETIOLOGY 
 
Despite considerable research in the last century, the aetiology and pathology 
of frozen shoulder remain enigmatic (Hannafin and Chiaia 2000). The 
prevalence is found to be approximately 2-3% of adults in the general 
population (Binder et al 1984; Hannafin and Chiaia 2000), and is thought to 
develop between the ages of 40 and 70 (Reeves 1975; Binder et al 1986; Stam 
1994).It rarely recurs in the same shoulder unless an injury or disease process 
predisposes the joint to repeat episodes of stiffness (Binder et al 1986; Di Fabio 
1998; Hand et al 2007). It is generally agreed that the non-dominant arm 
appears more likely to be involved (Kessel 1986; Neviaser and Neviaser 1987; 
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Fareed and Gallivant 1989). However, Bunker (1998), reports that the condition 
occurs with equal frequency in the left and right shoulders. With regard to 
gender, Neviaser and Neviaser 1987; Stam 1994 and Hand et al 2008, found 
that there is a greater occurrence in women. Bunker (1998) also disputes this 
reporting that there is equal prevalence between both genders; more recent 
studies showed a ratio of 1:1 male to female (Bunker 2009).  
 
Frozen shoulder usually presents unilaterally and the incidence of subsequent 
involvement on the contralateral side is 20% (Lundberg 1969; Hannafin and 
Chiaia 2000; Hand et al 2008). It affects 20% of people with diabetes and has 
been described as the most disabling of the common musculoskeletal 
manifestations of diabetes (Smith et al 2003; Kordella 2002).  
 
1.4 PATHOLOGY 
 
Although the aetiology of frozen shoulder remains elusive, the understanding of 
its pathogenesis is increasing. Generally, three schools of thought have 
emerged:  
 an inflammatory process (Simmonds 1949; Wiley 1991, Hannafin et al 
1994). 
 a fibrotic process (Ozaki et al 1989; Bunker and Anthony 1995; Hannafin 
and Chiaia 2000) and 
 an inflammatory process with subsequent reactive capsular fibrosis 
(Bunker et al 2000). 
 
Duplay (1872) theorized that the pathologic condition of frozen shoulder was 
found in the subacromial bursa but later Codman (1934) related the disorder to 
calcific tendonitis. Neviaser (1945) discovered a tight, thickened capsule that 
adhered to the humeral head. He described an inflammatory reaction that led to 
adhesions, specifically in the axillary fold and in the attachment of the capsule 
at the anatomic neck of the humerus. On biopsy and histological examination, 
he identified perivascular infiltration, capsular thickening, contracture and 
fibrosis. He proposed that the pathology primarily involved the shoulder 
capsule, suggesting the term „adhesive capsulitis‟ as a better name for the 
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disease (Figure 1.1). However, Lundberg (1969), Wiley (1991) and Bunker et al 
(1994), found no adhesions in their arthroscopic studies.   
 
Figure 1.1 Adhesive Capsulitis (A Frozen Shoulder)  
Back in Action (2005)  
 
 
           
                                                             
Simmonds (1949) agreed with Neviaser (1945) and speculated that a loss of 
motion at the glenohumeral joint was because of degenerative changes and 
secondary inflammation of the supraspinatus tendon. Lundberg (1969) also 
observed an inflammation of the capsule as a precursor of the process leading 
to stiffness, pain and capsular fibrosis but no significant number of inflammatory 
cells. Significant evidence exists in support of the hypothesis that the underlying 
pathological changes are synovial inflammation with subsequent reactive 
capsular fibrosis, making adhesive capsulitis an inflammatory and a fibrosing 
condition, dependant on the stage of the disease, (Bulgen et al 1982; Grubbs 
1993; Carr and Hamilton 2005). Several investigators have proposed an 
autoimmune basis for frozen shoulder (Bulgen et al 1984; Neviaser and 
Neviaser 1987). However, specific immunological studies reveal no evidence of 
any specific auto-immune or arthritic process (Bulgen 1984, Neviaser and 
Neviaser 1987; Bunker 1998). This fact is used in the differential diagnosis of 
frozen shoulder. There is general agreement that the pathology affects the 
glenohumeral capsular tissue and is particularly localised to the coracohumeral 
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ligament in the rotator interval (Neer et al 1992; Omari and Bunker 2001) (see 
Figure 1.2). 
 
Figure 1.2 The Shoulder Complex 
                                    
(www.stockmedicalart.com/medicalartlibrary/shoulder-joint-ligaments.html) 
 
Neer et al (1992) postulated that the coracohumeral ligament was contracted 
and Ozaki et al (1989) stated that the release of this ligament was curative and 
this was confirmed by Bunker et al (1994). Bunker et al (1994) observed that 
thickening and contracture of the glenohumeral ligament and rotator interval, 
acts as a check rein which prevents external rotation and causes global loss of 
active and passive movements. The contracture also causes superior 
translation of the humeral head leading to impingement and pain (Bunker 1998). 
Bunker and Anthony (1995) likened the changes of the glenohumeral capsule to 
Dupuytrens contracture in the palm. They reported that the pathological process 
is active fibroplastic prolification, accompanied by some transformation to a 
smooth muscle phenotype (myofibroblasts). The fibroblasts lay down collagen 
that appears as a thick nodular bond or fleshy mass. They further noted that in 
the shoulder capsule the inflammatory component was absent or localised to 
the synovial and subsynovial layers. The tissue observed was highly cellular 
with cells identified as fibroblasts and myofibroblasts and this has been 
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confirmed by Killian et al (2001). The findings by Hand et al (2007) confirm 
these results and support the theory that frozen shoulder is an inflammatory 
condition that progresses in a continuum to a fibrosing condition. In conclusion, 
all the histological evidence to date shows that this is a capsular contracture of 
the shoulder (Bunker 2009). Characteristically, pain precedes stiffness in frozen 
shoulder which suggests an evolution from inflammation to fibrosis. 
 
1.5 CLINICAL FEATURES 
 
In clinical practice, the tendency is to label any patient with a stiff and painful 
shoulder as a case of frozen shoulder. For years, much of the literature has 
referred to frozen shoulder as a self-limiting disease but the duration and 
severity may vary greatly (Codman 1934; Watson-Jones 1963; Reeves 1975). 
Even these studies describe the process as lasting a minimum of 12-18 months, 
before resolution. However there are those who suggest that it can last for as 
little as 6 months (Rizk and Pinals 1982; Grubbs 1993). Binder et al (1984) 
described frozen shoulder classically lasting for 18-24 months. Other studies 
have however challenged this popular belief. Simmonds (1949), Reeves (1975) 
and Shaffer et al (1992) agree that it can last two to three years, although report 
significant numbers of people have residual clinical detectable restriction of 
movement and smaller numbers‟ have residual disability (at seven years 50% 
had mild pain, stiffness or both). The clinical picture seen commonly by 
physiotherapists is characterised by this spontaneous onset of shoulder pain 
and progressive global stiffness of the gleno-humeral joint, accompanied by 
decreased function and significant disability (Reeves 1975; Neviaser and 
Neviaser 1987). The presence of night pain leads to disturbance of sleep and 
often difficulty lying on the affected shoulder (Shaffer et al 1992; Stam 1994). As 
the restriction in the motions increases, more difficulties are encountered with 
activities of daily living (Hannafin and Chiaia 2000). Routine radiographs are 
typically normal (Binder et al 1984). These are important to rule out serious 
pathology, abnormalities in the bone, joint or in the local soft tissues e.g. calcific 
deposit and are a prerequisite to a definitive diagnosis of frozen shoulder 
(Bunker 2009). 
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There is general agreement that the condition will pass through three stages 
(Reeves 1975). 
 
 STAGE I: -    involving pain 
 STAGE II: -   pain and restricted movement and finally  
 STAGE III: -  painless restriction 
Reeves first divided the clinical presentation of frozen shoulder into three stages 
in 1975, when he studied the natural history of 49 cases over 10 years (Table 
1.1). 
 
Table 1.1 Three stages of Classification (Reeves 1975) 
 
Freezing stage  
2.5-3 months  
 
The patient reports an insidious onset of diffuse shoulder 
pain, difficulty lying on the affected side and progressive 
loss of shoulder motion. Patients often identify pain at night. 
Ache is unrelated to activity and may be worse at rest. 
 
 
Frozen stage 
4-12 months 
(approx) 
 
The pain gradually subsides and is described as a dull 
aching type of sensation and occurs at the extreme of their 
available movement. Loss of motion plateaus with passive 
motion equal to active motion or gross reduction of 
glenohumeral movements, with near total obliteration of 
external rotation (Capsular pattern). 
 
 
Thawing stage 
12-42 months 
(approx) 
 
It is characterised by the gradual improvement of shoulder 
motion and the reduction of pain symptoms, mean duration 
from onset of frozen shoulder to resolution is over 30 
months.  
 
          
Neviaser and Neviaser (1987) have described an arthroscopic four stage 
classification (Table 1.2) and stressed the importance of an individual treatment 
plan based on an understanding of the clinical stages of the disease. More 
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recently, Hannafin et al (1994) have described a correlation between the 
arthroscopic stage, the clinical examination and the histological appearance of 
the tissues.  
 
Table 1.2 Four Stages of Classification (Neviaser and Neviaser 1987) 
 
Stage I 
0-3 months 
 
Preadhesive stage. A fibrinous synovial inflammatory 
reaction is detectable only by arthroscopy. The patients 
usually present with signs and symptoms of impingement 
syndrome. The main complaint is pain and minimum deficit 
in range of motion is detected. 
 
 
Stage II  
4-9 months 
 
Adhesive stage. The acute synovial inflammation is 
apparent on physical evaluation. Arthroscopic findings 
demonstrated that the normal spacing between capsular 
fold, humeral head and biceps tendon, glenoid and humeral 
head diminish significantly. The patient experiences severe 
pain and loss of motion. (Neviaser and Neviaser (1987) do 
not give this stage a name but compared to other 
classifications it appears to be equivalent to the Adhesive 
stage).  
 
 
Stage III 
10-15 months 
 
Maturation stage. This stage is evident by the maturation 
of the inflammatory process. The dependant fold is only half 
its original size and adherence between various structures 
are formed. 
 
 
Stage IV 
16-24 months 
 
Chronic stage. Capsular adhesions are fully mature and 
markedly restricted. Clinically, the shoulder is „frozen.‟ 
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Neviaser and Neviaser (1987) stressed that it is critical to remember that these 
represent a continuum of disease rather than discrete well-defined stages. 
 
More recently, a survey by Hanchard et al (2011) recommends a simple „pain-
predominant‟ or „stiffness-predominant‟ classification. This is also supported by 
Cyriax (1982), who suggests that there is a phase of increasing pain and 
stiffness, whereby pain is the predominant complaint until the pain abates 
leaving stiffness as the predominant complaint.  
 
The natural history of frozen shoulder is considered benign but because of the 
long period of pain and disability, many interventions have been considered. 
Roy and Oldham (1976), state “the bewildering numbers of pathological 
diagnoses are exceeded in number and confusion only by the different attempts 
at treatment of the condition” (Roy and Oldham, 1976:1322). Binder et al (1984) 
feel it is a chronic disorder leading to long-term disability but sometimes a 
residual stiffness may occur and complete resolution of symptoms remains 
controversial (Reeves 1975; Simmonds 1979; Shaffer et al 1992). Reeves 
(1975) in a prospective study of 45 patients with five to ten years follow up 
demonstrated that the time scales given within this typical presentation vary 
considerably. 42% had a deficit in their range of motion with 65% having a 
functional deficit at ten years. Whether a complete resolution actually occurs is 
disputed by many studies (Reeves 1975; Binder et al 1984; Shaffer et al 1992). 
Shaffer et al (1992), indicated that one-half of the patient population with frozen 
shoulder managed non-operatively, remained symptomatic an average of seven 
years later. They suggested that a minority of patients have a protracted course 
with ongoing restriction and concluded this made them question whether this is 
a benign self-resolving condition. These findings were also confirmed by Griggs 
et al (2000) Smith et al (2001) and more recently by the largest study to date by 
Hand et al (2008). In this study by Hand et al (2008), 273 patients were followed 
for up to twenty years and the results demonstrated that 41% of their patients 
had mild to moderate persistent symptoms at seven years and 6% had severe 
ongoing symptoms with pain and functional loss.  
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1.6 MANAGEMENT OF FROZEN SHOULDER 
 
Many studies have attempted to establish the most effective treatment for 
frozen shoulder but much debate still remains. Currently there is no agreement 
on the standard management of this condition (Dundar et al 2009). The lack of 
consensus on diagnostic criteria and concordance in clinical assessment 
complicates treatment choices. The controversy is due in part to a failure of 
many authors to precisely define and accurately identify frozen shoulder among 
other causes of shoulder pain and stiffness (Stam 1994; Green et al 2003; 
2009). Orthopaedic and physiotherapy interventions or treatment modalities 
have been advocated in the management of frozen shoulder in the past thirty 
years, to alleviate the signs and symptoms and aid recovery. 
 
1.6.1 Orthopaedic Management 
There is a considerable body of work devoted to the orthopaedic management 
of this condition but the aim of this study is to focus on the conservative 
physiotherapy management. Therefore, only a concise review of orthopaedic 
management follows. Initially, treatment is directed at pain relief. Non-steroidal 
anti-inflammatory drugs (NSAID‟s) are traditionally given but there are no 
randomised control trials that confirm the effectiveness of these. Oral 
corticosteroids have been recommended but little evidence exists to support 
their routine use (Buckbinder et al 2004; Dias et al 2005). Suprascapular nerve 
block (Dahan et al 2000) and steroid injection have been suggested by some 
authors (Rizk and Pinals 1982; Bulgen et al 1984; Carette et al 2003). However, 
this approach alone has not been shown to improve the range of shoulder 
motion (Lundberg 1969; Lee et al 1973; Rizk and Pinals 1982).  
 
Orthopaedic interventions that have been shown to produce successful 
outcomes in restoring function include; distension arthrography, manipulation 
under anaesthetic (MUA) and arthroscopic release.  
 
Distension arthrography was described by Andren and Lundberg as early as 
1965 and has been advocated as a means of expanding the contracted 
capsule. Rizk et al (1994) promoted it as a promising treatment. They 
performed a study of 16 patients and found that 13 experienced immediate pain 
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relief and increased shoulder mobility. This was also found by Buchbinder et al 
(2004) who demonstrated a significantly greater improvement in pain, function 
and active range of movement (ROM) in the group that received distension at 
three and six weeks.   
 
Manipulation under anaesthetic (MUA) is the established form of treatment 
(Snow et al 2009). It results in a rapid return of shoulder motion, although some 
authors disagree about whether it shortens the disease course (Lundberg 1969; 
Murnaghan 1990). Bunker and Anthony (1995) showed that 75% of their 
patients attained a near normal range of movement, 79% were relieved of their 
pain and 75% returned to normal within nine weeks. Some authors consider 
manipulation an effective intervention, whereas others claim that it is 
traumatising and may even exacerbate pain (Kivimaki et al 2007).  
 
Bunker (2005) suggests that arthroscopic release has transformed the 
management of this disease and recently in 2009 reports that it is still delivering 
relief of pain, undisturbed sleep and improved function in the majority of people 
with frozen shoulder. Ogilive-Harris et al (1995) compared the results of MUA 
versus arthroscopic release. Although both groups gained the same 
improvement in ROM, the arthroscopic group had significantly better pain relief 
and function. Harrymann et al (1997) demonstrated excellent results. The ROM 
went from 41% of the opposite side to 78% on the first day following surgery 
and 93% at the end of the study. Berghs et al (2004) demonstrated that 36% of 
patients experienced pain relief and reduced stiffness after one day following an 
arthroscopic release and 80% within two weeks.  
 
1.6.2 Physiotherapy Management 
Physiotherapy is often the first line of management for shoulder pain, yet its 
efficacy has not been established (Lynch 2002). The most recent and 
comprehensive reviews available are the systematic review by Cleland and 
Durall (2002) and the Cochrane review by Green et al (2003; 2009). In the 
review conducted by Cleland and Durall (2002) twelve papers met the inclusion 
criteria and were split into prospective (n=9), retrospective (n=1) and 
randomised clinical trials (n=2). Their methodological scoring criteria included 
points for identifying the stage of pathology, whether the frozen shoulder was 
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primary or secondary, duration of symptoms prior to intervention, and number of 
treatments. Due to the self-limiting nature of the condition these are important 
aspects to consider when reviewing the efficacy of treatment and are frequently 
omitted; this is therefore a strength of their work. However, this study is limited 
as it only searched two databases and the reviewer was not blinded to the aim 
of the study and was therefore a threat to the internal validity. They only found 
two randomised controlled trials (RCT‟s) and therefore highlighted the need for 
more prospective RCT‟s using a standardised outcomes assessment to judge 
the efficacy of various physiotherapy interventions on frozen shoulder. 
 
The results revealed many inconsistencies. There was considerable variation in 
intervention strategies, duration of treatment and outcome measures between 
the studies and lack of rigour and poor standardisation of terminology. This 
made it difficult to compare relevant published research and determine the 
effectiveness or economic efficiency of treatments. As most of the studies used 
complex interventions and combined treatment modalities, they argued that it 
was difficult to determine which elements of physiotherapy were efficacious. 
 
Green et al (2003; 2009) also highlighted this in their Cochrane review of 
physiotherapy interventions for shoulder pain. This review has been updated in 
2009; however there was no change to the conclusions. They stated that it is 
unusual for shoulder disorders to receive a single treatment in isolation, 
demonstrating a conflict between validity and clinical practice. Green et al 
(2003; 2009) reviewed twenty-six trials that met their inclusion criteria and were 
concerned by the low number of single modality studies. They identify this as 
one of the key areas to improve future research, along with larger trials of 
higher methodological quality, well-defined interventions and a validated 
inclusion/exclusion criterion. They concluded that there was no evidence that 
physiotherapy without concurrent interventions, such as corticosteroids, was of 
benefit for frozen shoulder. They stressed the need for trials of physiotherapy 
interventions for specific clinical conditions associated with shoulder pain. Four 
RCT‟s have been published since Green et al (2003; 2009) published this 
systematic review: Guler-Uysal and Kozanoglu (2004); Buchbinder et al (2007); 
Vermeulen et al (2006) and Johnson et al (2007). These authors examined 
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different types and combinations of treatments over different time periods and 
used a variety of self-report instruments to assess pain, function and quality of 
life. It is still unclear from these papers which interventions may be most 
effective. Both the number and diversity of treatments, which have been 
recommended, reflect the extremely general nature of the physiotherapy 
treatment for frozen shoulder. Therefore, there is yet no definitive agreement on 
the most effective form of treatment (Sun et al 2001). 
 
Physiotherapy management aims to relieve pain, promote healing, reduce 
muscle spasm, increase joint range of motion and strengthen weakened 
muscles and ultimately to prevent and treat functional impairment (Green et al 
2003; 2009). These include: heat or ice applications; Ultrasound; Interferential 
therapy; Transcutaneous Electrical Nerve Stimulation (TENS); pulsed 
electromagnetic field therapy; active and passive ROM exercises; 
Proprioceptive Neuromuscular Facilitation (PNF) techniques; manual physical 
therapy and laser therapy. 
 
 
Green et al (2003; 2009), concluded that vast range of recommended 
treatment, coupled with a lack of many conclusive studies in this area, means 
that there is little guidance for today‟s physiotherapist with patients with a 
diagnosis of frozen shoulder. Currently there is no robust evidence on the 
superiority of any one treatment modality compared to another (Callinan et al 
2003). Modern literature commonly recommends the use of multiple modalities 
which precludes the effectiveness of individual treatment (Cleland and Durall 
2002).  
 
The Chartered Society of Physiotherapy has completed a project on the 
management of frozen shoulder (Hanchard et al 2011). Conclusions drawn from 
these evidence-based clinical guidelines suggest that future researchers should 
report their physiotherapy interventions in sufficient detail to remove ambiguity 
consider multi-centre trials and focus on specific stages of frozen shoulder.  
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1.6.3 Exercise Therapy 
Research demonstrates considerable variability in methods of treatment; 
however, it has been shown for some time that virtually all of them advocate 
some form of exercise to restore movement (Lee et al 1973; Neviaser and 
Neviaser 1987; O‟Kane et al 1999). In clinical practice, exercises are almost 
always incorporated into the physiotherapy management of a patient with frozen 
shoulder. Whilst exercise is undoubtedly an important adjunct to treatment, its 
effectiveness as a sole treatment for frozen shoulder has not been thoroughly 
evaluated.  
 
Diercks and Stevens (2004) performed a randomised prospective study of 77 
patients with idiopathic frozen shoulder to compare the effect of intensive 
physical rehabilitation treatment. The patients were divided into two groups. All 
patients had more than 50% motion restriction for a period of three months or 
more. One group involved passive stretching and manual mobilisation 
(stretching group) with supportive therapy and the second with a regime 
including active and auto-assisted exercises, within the pain limits (supervised 
neglect group). All patients were followed-up for 24 months after the start of 
treatment. In the patients treated with supervised neglect, 89% had normal or 
near- normal painless shoulder function (Constant score >80) at the end of the 
observation programme 64% reached this result within 12 months. In contrast, 
in the group receiving intensive physiotherapy treatment, only 63% received a 
score of 80 or more after 24 months. The authors concluded that supervised 
neglect yields better outcomes than intensive physiotherapy and passive 
stretching in patients with frozen shoulder. However, they do not state where or 
how the sample was obtained, the frequency of treatment sessions or the 
compliance of patients. The study does not describe the validity or reliability of 
the measurement tools, who carried out the assessment and whether they were 
blinded to the intervention the patient received. One of the key findings was that 
intensive stretching prolonged the course of the disease and increased pain 
levels. This may be due to stretching into the painful range and could aggravate 
the symptoms and therefore increase the pain.  
 
Jurgel et al (2005) found that a four week course of physiotherapy treatment 
resulted in significant improvements in the range of movement (ROM), pain 
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levels, muscle strength and endurance in 10 patients with idiopathic frozen 
shoulder, who had pain for two weeks to three months duration. However, they 
continued to have reduced ROM and strength compared with their unaffected 
side or controls. Positions were standardised for measuring ROM and muscle 
strength and endurance. Unfortunately, only endurance in flexion was 
measured which was performed using a prolonged static posture. This does not 
relate to many functional activities. Pain was measured using a 10 point visual 
analogue scale (VAS). However it was unclear if this was at rest or during 
activity, or over what time period e.g. past day, past week. It was also unclear if 
pain was measured or whether this was asked pre or post assessment of ROM, 
muscle strength and endurance. They used a questionnaire to determine 
difficulties in activities of daily living (ADL). However a standardised validated 
questionnaire was not used and it was uncertain which activities were 
assessed. Additionally the ADL questionnaire was not repeated at the final 
assessment, thus giving no information on whether the improvement in ROM, 
pain, muscle strength and endurance relate to an improvement in the ability to 
carry out ADL. The sample was very small therefore affecting the 
generalisability of the findings to the general population. Moreover, recruitment 
and the inclusion and exclusion criteria were not stated. No power calculations 
were mentioned and it is questionable if 10 patients provide enough power to 
enable robust statistical analysis. Only one physiotherapist assessed muscle 
strength and endurance, one physiotherapist assessed ROM and one 
physiotherapist performed the therapeutic interventions. This does reduce error 
due to inter-rater variability and also reduces the variability in personal 
interaction between the treating physiotherapist and the patients in the study. 
However, it is unclear whether the assessing and treating physiotherapists were 
the same or different people. Though the participants achieved good results in 
this study it was through quite intensive input of up to an hour per day of mixed 
therapeutic modalities. A combination of pool and gym exercises, various 
electrotherapies and massage therapy were used and tailored to each individual 
participant. Whilst this is how patients tend to be treated in the clinical setting it 
is difficult to ascertain which intervention was beneficial and as none of the 
interventions are described it would be difficult to apply this to clinical practice.  
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There are no clear indications in the literature concerning the optimal treatment 
frequency and duration, but the trial physiotherapist hypothesised that the 
regime used would be intensive and long enough to induce changes. Moreover 
in the absence of scientific evidence regarding the effectiveness of multimodal 
physiotherapy programmes, this programme was developed in light of results 
obtained in studies of other groups with musculoskeletal disorders, in animal 
studies, and from the best available evidence (Grubbs 1993; Stam 1994).  
 
In reviewing the studies presented, it is evident that more research is needed in 
order to draw conclusions and establish an efficacious and clinically valid 
treatment method. As identified, this evidence needs to come from robust 
randomised clinical trials. Such trials need to clearly define the methodological 
approach used and include sufficient follow up length, with use of clinically valid 
and reliable outcome measures.  
 
1.7 SUMMARY 
 
In general, the natural history of frozen shoulder is uncertain. It remains 
controversial with the majority of long term follow up reports performed with 
evaluation of the patients‟ response to particular treatments. Difficulty exists in 
performing these studies owing to the ethical dilemma of assigning patients to 
an untreated group. Additional randomised, prospective studies are needed. 
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1.8 AIMS AND OBJECTIVES 
 
The aim of this study was to investigate the clinical effectiveness of common 
physiotherapy interventions in the treatment of frozen shoulder using the 
Constant score, the Oxford Shoulder Score (OSS), the Hospital Anxiety and 
Depression Scale (HADS) and the short form 36 item health survey (SF-36). 
  
The objectives were: 
 To determine if there is a difference in effect between the three treatment 
interventions: an Exercise Class plus home exercises (Exercise Class 
Group); Physiotherapy plus home exercises (Multimodal Group); home 
exercises (Home Exercise Group). 
 To explore what aspects of the clinical scores used are most affected at 
detecting change in the different treatment groups. 
 To determine if there is any change between the different time intervals at 
six weeks, six months and one year. 
 To provide recommendations for the best practice for the physiotherapeutic 
management of frozen shoulder. 
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Chapter 2 METHODS 
 
2.1 QUANTITATIVE EXPERIMENTAL METHODOLOGY  
 
Hypotheses are ideas based on some plausible factual knowledge about a 
problem (Currier 1990). The review of the literature demonstrates that the 
research which has investigated the conservative treatment of frozen shoulder 
is conflicting and unclear. The experimental hypothesis investigated in this 
thesis is stated as: 
 
Experimental Hypothesis  
H1 – The hypothesis is that there will be a significant difference between a 
home exercise programme alone, a home exercise programme combined with 
physiotherapy and a home exercise programme combined with an exercise 
class. 
 
Null Hypothesis 
H0 - The null hypothesis in this study is that there will be no significant 
difference between a home exercise programme alone, a home exercise 
programme combined with physiotherapy and a home exercise programme 
combined with an exercise class. 
 
Variables  
The independent variable is the one to be manipulated. The variable, which 
may change as a result of our manipulation of the independent variable, is 
called the dependent variable. (Clegg 1991; Hicks 2004) 
 
To decrease the risk of error in the results, it is important that the researcher 
ensures that the measurement tools are valid and reliable (Domholdt 2000). 
Validity is ensuring that the researcher is measuring what is intended to be 
measured (Sim and Arnell 1993). Reliability is the ability to reproduce the 
results. The variables being manipulated in this study are: 
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Independent Variable 
 Treatment: Exercise Class, Multimodal or Home Exercise Group. 
 
Dependent Variables 
 Range of shoulder motion 
 Pain 
 
Controlled Variables 
 Standardised number and duration of treatment sessions, and 
standardised treatment procedures for patients within each group. 
 Standardised assessment protocol and exercise programme for all 
patients. 
 
2.2 DESIGN OF THE TRIAL 
 
The research design chosen to confirm or negate the study hypothesis and to 
fulfil the study objectives was a randomised control trial (RCT). This employs a 
method where patients are randomly allocated to a group and conforms to the 
CONSORT statement (Altman et al 2001). Randomisation in this way minimises 
the influence of selection bias on the conclusions of the study and is the most 
effective method of removing the influence of both known and unknown 
confounders (Bailey 1997). Thus, clinical studies where randomisation is utilised 
are often more able to find significant outcomes in the effectiveness of 
treatments (Hicks 2004). 
 
2.3 SETTING 
 
Patients eligible for the trial were new referrals to the physiotherapy clinics 
within Ashton Wigan and Leigh Primary Care Trust and Wrightington, Wigan 
and Leigh NHS Foundation Trust, with a diagnosis of frozen shoulder. The 
district has a total patient population of 332,221 (2007/2008). There are 
approximately 6,500 new musculoskeletal physiotherapy referrals per year.  
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2.4 RECRUITMENT 
 
All GP and Consultant referrals were triaged by the upper limb team. Patients 
selected for assessment were those with a diagnosis of frozen shoulder on their 
referral details. The physiotherapists in the team then assessed each potential 
patient and completed the inclusion sheet (Appendix One). The trial 
physiotherapist then reviewed each potential patient to ensure that they would 
be suitable to enter the study. This is shown in the CONSORT flow diagram of 
patient recruitment (Figure 3.1). 
 
2.5 ETHICAL CONSIDERATIONS 
 
The ethics of the study were considered following guidelines issued by the local 
National Health Service (NHS) research ethics committee and complied with the 
principles enunciated in the Declaration of Helsinki (2008). Hicks (2004) 
recommend that any piece of research must endeavour to protect the rights, 
dignity, physical and psychological welfare of the patients. Prior to embarking 
on the study the relevant committees were consulted and informed about the 
proposed research who subsequently gave the study ethical approval.  
 
In the study, patients in all three groups were given standard clinically accepted 
treatment to alleviate the signs and symptoms of frozen shoulder as there was 
no „non-treatment‟ control group. This design ensured that no patient entering 
the study was denied potentially beneficial treatment for their condition. There 
was minimal risk of complications arising from any of the treatments and to 
ensure patient safety, all patients entering the study were suitable for exercise 
therapy. Following completion of the trial all patients were given the option to 
have continued physiotherapy treatment or to have an orthopaedic consultation 
should they feel this necessary. 
 
Prior to obtaining patient consent to enter into the study a written patient 
information sheet (Appendix Two) was provided. All data collected during the 
study was protected in accordance with the 1998 Data Protection Act. 
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Approval was sought and gained, through the author‟s employment trust, for 
trial data to be stored electronically on a secure NHS computer. Confirmation of 
registration with the information commissioner  was provided by the Information 
Technology Manager (Health Informatics Department) 
(www.informationcommissioner.gov.uk). 
 
The original data sheets were stored in locked filing cabinets on secure 
premises. All coded data, both electronic and hard copies, were securely stored 
separately from identifiable patient details. Potential patients were assured of 
the above measures to protect privacy, confidentiality and anonymity prior to 
consenting to involvement in the study and before collection of any data or 
personal details. 
 
Confidentiality was maintained at all times with regard to patient information. 
Following a GP or Consultant referral for physiotherapy, patient records are 
inputted onto the electronic hospital patient system which is accessed by 
personal password (changed monthly). Patients cannot be identified on this 
system as participating in the study. It is only by correspondence with their GP 
or Consultant can such information be available. Any information for analysis on 
a home computer was pseudonymised in accordance with Caldicott regulations. 
Any information for the study was adequate, relevant, accurate and up to date. 
The use and storage of study information on a home computer was backed by 
floppy disc and password protected. Patients have the right under Caldicott to 
view their current written physiotherapy records but this was not requested by 
any of the patients in the study. 
 
A warning that non-NHS to NHS e-mail is neither secure nor encrypted was 
explained to all trial patients and therefore that it should not be used in the 
communication of sensitive personal or identifiable study data. Furthermore, 
assurance that the trial physiotherapist would not use this means of 
communication to transfer information was given.  
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2.6 INFORMED CONSENT 
 
The trial physiotherapist was responsible for gaining informed consent. Patients 
participated in the study on a voluntary basis and written consent was obtained 
from the patient prior to commencement (see Appendix Three). The patients 
received written and verbal explanations of the purposes and procedure of the 
study. This was in the form of the Patient Information Sheet and provided 
explanation of the nature of the study and methodology (Appendix Two). This 
was provided at recruitment a minimum of one week prior to the study. This 
consultation enabled patients to verbally establish comprehension of the study 
requirements, clarify individual queries and confirm agreement to enter the 
study. If no decision was made or a negative response obtained, patients then 
entered the main stream referrals and standard treatment was offered based 
upon the initial assessment. 
 
The patient information sheet was developed in accordance with guidelines 
produced by the Central Office for Research Ethics Committee (2001), 
(www.corec.gov.uk). The REC reference number is 05/Q1401/86 approved by 
Stockport Local Research Ethics Committee. 
 
2.7 ELIGIBILITY CRITERIA 
 
The determination of inclusion and exclusion criteria was made not to limit the 
external validity of the study, as the more stringent the criteria the less likely the 
sample will be a representative of the population (Currier 1990). A number of 
previous studies were consulted when determining the inclusion and exclusion 
criteria. An extensive review of the literature was undertaken to ensure 
consistency with other studies. 
2.7.1 Inclusion Criteria 
 Age 40 to 70 years old  
 Patients reported local shoulder pain, frequently present over either the 
anteromedial aspect of the shoulder extending distally into the biceps 
region, or over the lateral aspect of the shoulder extending into the lateral 
deltoid region.  
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 Spontaneous onset of a painful stiff shoulder      
 Marked loss of active and passive global shoulder motion, with at least 
50% loss of external rotation 
 Symptoms present for at least three months. Normal x-rays on 
anteroposterior and axillary lateral radiographs of the glenohumeral joint      
(Griggs et al 2000; Wies 2005; Yang 2007) 
2.7.2 Exclusion Criteria  
 Radiographic pathological findings or glenohumeral osteoarthritis on X-
ray 
 Clinical evidence of significant cervical spine disease 
 History of significant trauma to the shoulder 
 Local corticosteroid injection or any physiotherapy intervention to the 
affected shoulder within the last three months  
 Cerebral vascular accident affecting the shoulder 
 Inflammatory joint disease affecting the shoulder 
 Bilateral frozen shoulder due to possible underlying systemic cause  
 Thyroid disease 
 Any coronary event, post coronary artery by-pass or catherisation prior to 
the clinical appearance of frozen shoulder 
 Prior surgery, dislocation or fractures on the affected shoulder  
 Active medico legal involvement  
(Maricar and Chok 1999; Carette et al 2003; Wies 2005) 
 
Inclusion criteria were representative of the typical features of frozen shoulder 
(Miller et al 1998). The exclusion criteria served to eliminate patients with an 
inappropriate diagnosis of frozen shoulder and patients with other inappropriate 
medical conditions complicating the pathology.  
 
2.8 BASELINE ASSESSMENT 
 
Patients were assessed by the trial physiotherapist and inclusion and exclusion 
criteria verified. To facilitate this process and to confirm a differential diagnosis 
of frozen shoulder, patients underwent a standardised subjective and objective 
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examination, as recommended by Wadsworth (1986) and Bowling et al (1986). 
Routine radiographs were performed. 
 
Before participating in the study, patients gave written informed consent. Once 
consent was obtained, assessments of the trial outcome measures using 
standard assessment forms were undertaken (Appendix Four). After the 
baseline measurements were carried out, an administrative assistant assigned 
the patients to the intervention groups according to the randomisation scheme. 
The baseline record included age, gender, hand dominance, duration of 
symptoms, manner of onset of pain, precipitating trauma, previous 
management, history of diabetes and previous history of frozen shoulder. 
Following baseline evaluation outcome measures were taken at six weeks, six 
months and at one year. The patients who expressed a desire to withdraw from 
the trial due to inability to cope with ongoing symptoms were recorded as 
having failed treatment and offered alternative treatment. Assessment at each 
time point was performed by the trial physiotherapist who was blinded to 
treatment allocation. To facilitate control of extraneous variables, all outcome 
assessments were carried out in a consistent environment, e.g. room 
temperature, lighting. 
 
2.9 RANDOMISATION 
 
Randomisation took place after written consent was obtained from the study 
patients and baseline information was gathered. Patients meeting the inclusion 
criteria and agreeing to participate in the study were then randomly allocated 
into one of the three treatment groups: 
 
 Group one : Exercise Class plus home exercise (Exercise Class) 
 Group two : Physiotherapy plus home exercise (Multimodal) 
 Group three : Home Exercise Group   
 
The groups were identified to reflect current clinical practice. Consenting 
patients were randomly assigned by computer generated permuted block 
randomisation. The assignment scheme was generated by a statistician 
independent of the research team using computer-generated random numbers. 
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A random block length (chosen with equal probability from blocks of length six, 
nine or 12) was used. The allocation schedule created was provided securely to 
the Research and Development Department at Wrightington Hospital in April 
2006 and staff in department used this to create sequentially numbered, sealed, 
opaque envelopes each containing a slip indicating which of the three different 
interventions a patient was to receive. The allocation schedule and envelopes 
were held by the Research and Development co-ordinator. The patient was 
then given an envelope with a treatment allocation and this was blinded to the 
trial physiotherapist. An independent person noted the number and 
corresponding name of the patient which was then kept in a locked filing 
cabinet. All the patients‟ records, questionnaires and post treatment information 
regarding age, sex, source of referral were recorded by the randomisation 
number and confidentiality was maintained. The patients were given one week 
to confirm agreement to enter the study. 
 
2.10 INTERVENTIONS 
 
All the patients were asked to have no other adjuvant therapy during the study 
except medication such as analgesics including non-steroidal anti-inflammatory 
drugs. Adherence was monitored via communication with the GP and by 
interviewing the individuals in the study. They were asked to record if they 
received any additional treatment. A letter was sent to the GP explaining the 
trial and the importance of limiting concurrent interventions (Appendix Five). 
Patients in all groups were given an information booklet (Appendix Six) 
containing advice on pain, heat, posture and a home exercise programme and 
were instructed how to perform the home exercise programme. Advice about 
frequency, intensity and progression of the exercises, was also given to aid 
compliance with the exercises. These home exercises were demonstrated by 
the trial physiotherapist. The patients went through the exercises under the 
supervision of the trial physiotherapist to ensure correct therapeutic exercises 
were performed. They were instructed when performing their exercises to begin 
the exercises one to two times per day; gradually build up the number of 
repetitions and not force through pain (Wies 2005) (Appendix Six). The outcome 
measures were also assessed at this point for all three groups. 
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The three groups continued as follows: 
 
Patients randomised into Group Three started their programme immediately, 
patients randomised into Groups One and Two started their programme 
approximately one week later depending on the patient‟s availability. The 
physiotherapists involved in the treatment programme were all clinical 
specialists each with in excess of sixteen years of clinical experience and 
specialisation in the treatment of shoulder disorders for the past nine years. 
After the six weeks intervention, all patients in all three groups were reviewed 
by the trial physiotherapist, who remained blind to group allocation and their 
outcome measures were recorded. 
 
Group One: Exercise Class 
This group was assigned to a physiotherapist with 16 years of experience in 
musculoskeletal physiotherapy, specialisation in the treatment of shoulders for 
the past nine years. Treatment consisted of group therapy scheduled twice a 
week for a period of six weeks. Patients performed a 50 minute exercise circuit 
comprising of 12 stations. Each station exercise was performed for four 
minutes, comprising of ROM and stretching exercises for all directions of 
shoulder movement (Appendix Seven). Careful instruction was given by the 
physiotherapist when demonstrating the exercises (Sun et al 2001). Exercise 
sheets were given with the name of the exercise, to ensure compliance and aid 
understanding of the circuit (Appendix Seven). Strengthening exercises were 
included in week three. 
 
 
Group Two: Multimodal 
This group were assigned to a physiotherapist with 18 years clinical experience 
in musculoskeletal disorders and specialisation in the treatment of shoulder 
conditions for the past eleven years. Multimodal physiotherapy consisted of two 
sessions of individual treatment weekly over a period of six weeks. They were 
also instructed on the specific shoulder exercises in the home exercise 
programme and given the information leaflet. The treatment programme was 
based on local practise and expert opinion in the absence of clear consensus in 
the literature (Ryans et al 2005). Treatment could be adjusted according to the 
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severity of symptoms. It included Maitland mobilisations, which were 
progressed as the condition improved, soft tissue massage, myofascial trigger 
point release, heat, stretches and the identical home exercise programme as 
given to each of the other groups. 
 
Group Three: Home Exercise Group 
Patients were instructed on the specific shoulder exercises in the home 
exercise programme and given the information leaflet as described above. They 
received instruction and advice only and were reviewed in six weeks by the trial 
physiotherapist.  
 
2.11 STANDARDISATION OF INTERVENTIONS 
 
All patients were given standardised advice and instructed by the trial 
physiotherapist in an identical home exercise programme (Van der Windt et al  
1998). This was reinforced in an information booklet given to each patient. The 
trial physiotherapist taught the home exercises and gave advice repeated in the 
information booklet (Appendix Six). 
 
It is rare to find any clinical measurement tool to be 100% reliable as all 
instruments and measures are fallible. The difference between the true 
measure and actual measure is known as measurement error (Bruton et al 
2000). To enhance the reliability and reduce measurement error, the trial 
physiotherapist measured all patients ROM using the standardised procedure 
detailed in Norkin and White (2003)(Appendix Eight).  
[See 2.13.1.1 Goniometry]. 
 
2.12 BLINDING PROCEDURES 
 
It was impossible to blind patients regarding treatment but patients were 
instructed not to reveal what group they were in and what intervention they had 
been given. 
 
The trial physiotherapist was unaware of the treatment allocation and was not 
working where the treatment was administered.  
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The Group two physiotherapist only worked with the patients in this group and 
provided this intervention only. This physiotherapist worked in Ashton, Leigh 
and Wigan PCT and had no contact with the Group one physiotherapist. The 
Group one physiotherapist only worked at Wrightington Hospital where the 
exercise class was held.  
 
The physiotherapists who treated the subjects in conjunction with the trial were 
not involved in any other aspect of the study. Both physiotherapists and patients 
never attended the other group or intervened in any of the sessions. 
 
2.13 PRIMARY OUTCOME MEASURE 
 
2.13.1 Constant Score 
The primary outcome measure was The Constant-Murley Score (Constant and 
Murley 1987). Since its introduction in 1987 it has evolved to be the functional 
score currently recommended by the European Society for Surgery of the 
Shoulder and the Elbow and by the British Elbow and Shoulder Society (Walton 
et al 2007). This score reflects shoulder function with accuracy, reliability, and 
reproducibility (Gazielly et al 1994; Bankes et al 1998; Yian et al 2005). It is 
easy to use with a high intraobserver reliability and low interobserver error 
(Conboy et al 1996; Thompson et al 2001). This scoring system combines 
physical examination tests with subjective evaluations by the patients. The 
subjective assessment consists of 35 points and the remaining 65 points are 
assigned for the physical examination assessment. The subjective assessment 
includes a single item for pain (15 points) and four items for activities of daily 
living (work four, sport four, sleep two, and positioning the hand in space 10 
points). The objective assessment includes: range of motion (forward elevation, 
10 points; abduction, 10 points; external rotation, 10 points; internal rotation, 10 
points) and power (scoring based on the number of pounds of pull the patient 
can resist in abduction to a maximum of 25 points). The total possible score is 
therefore 100 points. Low scores denote significant pain and poor function. The 
minimal clinically important difference (MCID) is the smallest change in score 
that patients perceive as meaningful and which would cause clinicians to 
consider a change in the patients‟ management (Fayers and Machin 2007). 
There is no data which clearly state the MCID for the Constant score. However, 
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in clinical practice we would normally consider a change of approximately 15 
points to be clinically important. The publication by Constant and Murley (1987), 
in which they describe the instrument does not include methodology for how it 
was developed and more specifically, the rationale for item selection and 
relative weighting of the items. The strength of the instrument is that the method 
for administering the tool is quite clearly described, which is an improvement on 
pre-existing tools (Appendix Four). 
2.13.1.1 Goniometry 
One component of the Constant score is goniometry. Active ranges of shoulder 
movement (flexion, lateral rotation and medial rotation) were measured using a 
universal goniometer. With frozen shoulder however, it was difficult to achieve 
the recommended 90 degrees abduction starting position in order to measure 
rotation. The ranges of medial and external rotation were measured at the 
maximum pain free angle of abduction as recommended by Moore (1949). This 
angle was recorded during baseline evaluation and subsequently, when the 
outcome measures reassessed this angle was maintained to ensure 
comparability of results. Each movement was measured three times and the 
average taken. Full details of the procedure are given in Appendix Eight. This 
procedure has been endorsed by Gajdosik and Bohannon (1987). The results 
from one tester have been shown to be more reliable (Intraclass correlation 
coefficients of between 0.88-0.93) (MacDermaid et al 1999). The same 
goniometer was used throughout the testing as some suggest this to be more 
reliable and necessary when the effect of an intervention is to be assessed 
(Goodwin et al 1992; MacDermaid et al 1999). Others have suggested that this 
makes no difference to the reliability (Riddle et al 1987). For repeated measures 
of the ROM of the shoulder, the best of three readings were chosen. Maricar 
and Chok (1999) in their study using individuals with frozen shoulder found 
doing so reflected the maximum ROM achievable in that session. However, 
averaging more than one reading has been shown to minimally reduce variation 
among readings (Rothstein et al 1983; Stratford et al 1984) and therefore not 
essential in stable musculoskeletal conditions of the shoulder (Gajdosik and 
Bohannon 1987). Goniometry is the most versatile and commonly used 
assessment tool for measurement of ROM in clinical practice (Gajdosik and 
Bohannon 1987). From a review of the evidence it appears goniometry has 
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been proven to be a reliable and valid measure of shoulder movement 
(MacDermaid et al 1999; Hayes et al 2001). Goniometers are generally 
accepted to be valid tools, demonstrating good face validity (Gajdosik and 
Bohannon 1987; Williams and Callaghan 1990). 
 
Measurements were carried out in the same sequence at each attendance and 
were recorded on a standard data sheet (Appendix Four). Extension was 
excluded as in all other studies on frozen shoulder, being the least affected 
movement (Cyriax and Cyriax 1983).  
 
2.13.1.2 Pain (VAS) 
Melzack and Wall‟s Gate Control Theory (GCT) (Melzack and Wall 1982), 
describes pain as a complex experience comprising sensory, emotional and 
cognitive dimensions. This model suggests whilst pain can be understood in 
terms of a stimulus-response pathway this pathway is complex and is mediated 
by a network of interacting processes leading to an integration of psychological 
factors into the traditional biomechanical model of pain. An understanding of 
pain is helpful in the treatment of frozen shoulder. Pain was measured at rest, 
during functional movement and at night. The patient was asked to identify the 
worst pain they felt when the shoulder was at rest, with use and at night by 
marking a visual analogue scale (VAS), at the point that corresponded with this 
level. The VAS scale is a 10cm line, 0 being no pain; 10 being the worst pain. 
Scale values are then obtained by measuring the distance from zero to that 
mark. It is used extensively in Orthopaedics. Revill et al (1976) and Price et al 
(1983) both conclude that the VAS provides a reliable method for measuring 
pain and is sufficiently sensitive to detect distinct differences in pain experience. 
The Price study involved 30 chronic pain patients and 20 health volunteers and 
assessed VAS responses to experimental pain and to different levels of chronic 
pain. This study found the VAS reliable for both experimental and chronic pain. 
It is a simple, easy to use measurement tool that the majority of patients and 
experimental subjects can easily respond to (Huskisson 1974; Price et al 1983).  
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2.14 SECONDARY OUTCOME MEASURES  
 
2.14.1 The Oxford Shoulder Score (OSS) 
This was developed by Dawson et al (1996). This score is a condition based 
questionnaire which is completed by patients unaided. It is short, practical, 
reliable, valid and sensitive to clinically important changes (Dawson et al 1996; 
Othman and Taylor 2004). The assessment is based on the symptoms 
experienced in the shoulder during the preceding four weeks and therefore, 
reflects their condition at the time of completion of the questionnaire. It contains 
12 items each of which has five categories of response. There are four items for 
pain and eight items for activities of daily living (dressing, using a car or bus, 
using a knife, shopping, carrying a tray, brushing your hair, hanging up clothes 
and washing yourself). Scores are added to give a single score, with a range 
from 12 (best) to 60 (worse). The score can also be expressed as a percentage, 
where 12 points = 100% and 60 points = 0%. It is intended for use as an 
outcome measure during specialist shoulder treatment and imposes very little 
burden on the patient (Appendix Four). 
 
2.14.2 Hospital Anxiety and Depression Scale (HADS)  
Several measures of depression and depressive symptoms have been 
developed and used extensively both clinically, in orthopaedics and in the 
research setting. However, the HADS (Zigmond and Snaith 1983) has proved to 
be a reliable and valid tool to assess emotional distress in medical populations 
(Herrmann 1997). More recently it has been suggested that HADS may be 
suitable for use as a screening tool for use in the rehabilitation settings with 
musculoskeletal patients (Harter et al 2001; Pallant and Bailey 2005).  
Moreover, despite its brevity, it also screens for possible anxiety and depressive 
symptomology similar to more comprehensive clinical measures. HADS 
consists of 7 depressive items measuring cognitive and emotional aspects of 
depression (HADS – D) and 7 anxiety items focusing on emotional aspects of 
anxiety (HADS – A ). It was developed for general medical out patients between 
the ages of 16 to 65 and has been extensively used effectively, primarily with 
psychiatric and medical patients, as well as the general population, students 
and non-patients with chronic medical conditions. HADS utilises a four point 
scale ranging from 0 to three with higher scores indicating greater severity. The 
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authors recommended cut off scores for the sub-scales which are 0 to seven 
considered non-case, eight to 10 considered possible case and 11 to 21 
considered probable case. The HADS is not a diagnostic tool as it is a poor 
predictor of making a specific diagnosis (Silverstone 1994). It was designed to 
identify probable „cases‟ of anxiety and depression. Average sensitivities and 
specificities are >0.80 which is similar to other self-rating screening tools 
(Herrmann 1997) (Appendix Four).  
 
2.14.3 The Short Form 36 Health Survey (SF-36) 
This is a widely used, self administered, 36 item generic indicator used to 
assess general health (Ware and Sherbourne 1992). It has recently been 
applied to the evaluation of shoulder disorders (Smith et al 2000). This is a 
questionnaire designed to assess eight dimensions of health status, which 
includes physical functioning (10 items), role limitations due to physical health 
problems (four items), bodily pain (two items), social functioning (two items), 
mental health (five items), role limitations due to emotional problems (three 
items), vitality and general health perceptions (five items). Each of the eight 
subscales is rescaled from 0 (poor health)-100 (good health); with a higher 
score indicating better health. For norm-based scores, any score above or 
below 50 can be considered above or below the population average health 
status for that dimension and each point on the scale is 1/10 of the standard 
deviation. Population norms are available for the US and the UK. In the UK they 
are given by age, sex, socioeconomic class and for chronic health conditions 
(Moncur 2003). It is the most widely used health status measure world wide. 
Overall, the SF-36 in a review of existing outcome tools struck the best balance 
between length, reliability, validity, responsiveness and experience in large 
populations of patients with back pain (Bombardier 2000) (Appendix Four)  
 
2.15 SAMPLE SIZE 
 
Based on the judgement of what constitutes a clinically significant difference on 
the primary outcome and variability estimates from previous studies, a sample 
size of 132 (44 per group) was planned (Yang et al 2007). The sample size 
calculation suggested that, to achieve 80% statistical power using a significance 
level of 5%, the sample size providing outcome data needed to be at least 39 
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per group (allowing for 10% dropout), to detect a clinically-significant between-
groups difference of 15 points on the Constant score, assuming a standard 
deviation of 20 points (based on the results of previous studies). We inflated the 
sample size to 44 in each group to allow for 10% dropout. The calculation was 
based on three pairwise comparisons and a two-sample t-test. The further use 
of covariates, such as the baseline value of the Constant score, should further 
improve the power of the study.  
 
Calculation of adequate sample size was important in order to make sure the 
sample is representative of the population (Currier 1990) the larger the sample 
size the less likely the researcher is to obtain negative results or make incorrect 
inferences about the collected data (Currier 1990). This is often referred to as a 
Type II error. The experimental hypothesis is rejected in favour of the null 
hypothesis when the data does, in reality, support the experimental hypothesis. 
This can be thought of as a „false negative‟ finding (Hicks 2004). It is also 
possible to obtain a significant result and thus reject the null hypothesis, when 
the null hypothesis is in fact true. This is called a Type I error and may be 
thought of as a „false positive‟ result.  
 
If the sample size is too small, then the results will be unable to be generalised 
to the population from which the sample was drawn (Hicks 2004). However if 
the sample size is too large, this could result in a waste of the researcher‟s 
resources, as the researcher would have to extend the study. This can also be 
considered to be unethical as it wastes patients‟ time who have agreed to take 
part. It is therefore important that a power calculation is carried out to 
scientifically determine the correct sample size.  
 
A sample of convenience was used i.e. patients referred for physiotherapy in 
the Ashton, Leigh and Wigan PCT. Currier (1990), reports that this method is 
often used in health related research as ethical constraints require that informed 
consent from subjects is needed prior to participation in the study. However, 
statisticians have reservations about this method of sampling and it offers no 
choice of subjects (Currier 1990). As the trial physiotherapist works at 
Wrightington Hospital and in Ashton, Leigh and Wigan PCT, it is of practical 
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convenience in regards to travel and costs that the sample is derived from 
within this population.  
 
2.16 METHOD OF ANALYSIS 
 
Data was analysed within groups to assess the effects of each intervention on 
the outcome measures and between groups, to compare the effects of the 
intervention. Descriptive statistics including means and standard deviations on 
interval/ratio data and frequencies with percentages on categorical data are 
presented. All data were tested to determine if normally distributed. If normally 
distributed a repeated measures one-way analysis of variance (RM ANOVA) on 
the outcome data was conducted. This included prognostic measures using the 
baseline value of the outcome measure as a covariate. All data were tested 
using Mauchly‟s test for sphericity, if this was not significant sphericity was 
assumed. If Mauchly‟s test for sphericity was found to be significant then the 
Greenhouse-Geisser method was used. Pairwise comparisons using the Least 
Squares Difference were conducted to investigate the differences between the 
different treatment groups and at the different time intervals following 
intervention. 
 
The baseline (pre-intervention) measurement is included as a covariate as it will 
be related to the repeated measurements following introduction of the different 
interventions rather than being an outcome of the intervention. The effect of the 
intervention (strictly speaking the average effect of the intervention over time) is 
then tested via the main effect of intervention group, whether the effect of the 
intervention varies over time is represented by the interaction between the 
intervention group and the repeated group and the repeated factor over time.  
The level of rejection of the null hypothesis was p<0.05 for all measures 
although the interaction between intervention group and time was tested using 
p<0.10 as the study was not powered to detect such trends. 
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Chapter 3 RESULTS 
3.1 RECRUITMENT 
 
A total number of 850 patients were initially recruited during a one year period 
between September 2006 and September 2007; 370 were excluded; 315 did 
not fit the inclusion criteria, and 70 refused to participate. The study was 
stopped due to the time restraints given for the Masters in Research. Thus 75 
patients entered the study and were randomly assigned to one of three groups.  
 
A total number of eight patients did not attend (DNA) follow up, despite being 
contacted and given another appointment. This subsequently led to incomplete 
data collection up to six months but all patients were reassessed at one year 
(intention-to-treat). Two patients were from Group one – Exercise Class, three 
patients were from Group two –Multimodal and three patients from Group three 
– Home Exercise Group. One patient died from other unrelated causes at six 
months from Group one – Exercise Class. One of the patients in Group two –
Multimodal telephoned at six weeks, and two of the patients in Group three – 
Home Exercise Group telephoned at six months to say their pain was too much 
to tolerate and were given an injection. They were reassessed at one year. One 
patient in Group two asked to see the Consultant but was given no further 
intervention and again reassessed at one year. At six months, one patient in 
Group one reported having lower limb problems and two patients in Group two 
reported having other upper limb problems and cardiac investigations, however 
they all completed the study. None of the other patients reported receiving any 
other treatments or interventions (Figure 3.1). 
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Figure 3.1 Flow diagram to communicate patient flow throughout the study 
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3.2 PATIENT CHARACTERISTICS 
 
The mean age of the sample was 51.13 years old (SD 6.84). The ratio of female 
to male was 1:1.14. The dominant arm was affected in 53 percent of the study 
population. 73 percent of patients were right-handed. The mean duration of 
symptoms was 5.79 months (SD 1.48). The primary analysis was intention-to-
treat and involved all patients who were randomly assigned. All data was 
recorded to two decimal points. An independent person checked raw data for 
accuracy. 
 
Table 3.1 Baseline Characteristics 
 
 Group One: 
Exercise 
Class 
Group Two: 
Multimodal 
Group Three: 
Home 
Exercise 
 
Age Mean Range 
(in years) 
 
 
51.27  
(SD 7.27) 
 
50  
(SD 6.06) 
 
52.8  
(SD 7.18) 
 
Male Gender n(%) 
 
12(48) 
 
 
10(42) 
 
13(50) 
 
Female Gender n(%) 
 
 
13(52) 
 
14(58) 
 
13(50) 
 
Affected Shoulder  
Right n(%) 
 
 
11(44) 
 
11(45) 
 
14(54) 
 
Affected Shoulder 
  Left n(%)  
 
 
14(56) 
 
13(54) 
 
12(46) 
 
Dominant Arm 
Right n(%) 
 
18(72) 
 
18(75) 
 
19(73) 
 
Dominant Arm  
Left n(%) 
 
7(28) 
 
6(25) 
 
7(27) 
 
Diabetic n(%) 
 
 
2(8) 
 
9(37) 
 
2(8) 
 
Mean Duration (in 
months) 
 
 
6.12 
(SD1.68) 
 
5.36 
(SD1.28) 
 
5.84 
(SD1.4) 
 
38 
 
3.3 ANALYSIS OF THE PRIMARY OUTCOME MEASURE (CONSTANT 
SCORE)  
3.3.1 Analysis of the Constant Score between the different time intervals 
and treatment groups 
Figure 3.2 shows the mean values of the Constant score. The Constant score 
combines subjective and objective measures to produce a 100 point score. This 
is derived of four parameters – Activities of Daily Living (ADL), Range of 
Movement (ROM), pain and strength.  
 
Figure 3.2 Mean Constant Score value for each treatment group at six weeks, 
six months and at one year for the Constant score.  
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A repeated measures ANOVA did not show a significant difference in the 
Constant score between treatment groups (p=0.188) but did show a significant 
difference between different time intervals (p<0.001). There was no significant 
difference between the profile of recovery between the three treatment groups 
(p=0.188).  
 
However, a further analysis using a pairwise comparison allowed the 
intercomparison of the individual treatment groups. The Exercise Class showed 
a significantly better score than the Multimodal and the Home Exercise Groups 
(p<0.001). The Multimodal Group showed a significantly better score than the 
Home Exercise Group (p=0.002)(Table 3.2). 
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Table 3.2 Pairwise comparison between overall means of the different 
treatment groups for the Constant Score.  
Pairwise Comparison Mean 
Difference 
Standard Error p value 
Exercise Class vs. 
Multimodal 
10.7 2.871 <0.001 
Exercise Class vs. 
Home Exercises 
20.304 2.936 <0.001 
Multimodal vs.  
Home Exercises 
9.606 2.970 0.002 
Adjustment for multiple comparisons: Least Significant Difference  
A pairwise comparison showed a significant difference in the Constant score 
between six weeks and six months (p<0.001), six weeks and one year 
(p<0.001) and between six months and one year (p<0.001)(Table 3.3). This 
shows a continued improvement over time, Figure 3.2. 
 
Table 3.3 Pairwise comparison between the different time intervals for the 
Constant Score. 
Pairwise Comparison Mean 
Difference 
95% Confidence 
Interval for Mean 
Difference 
p value 
Lower 
Bound 
Upper 
Bound 
six weeks vs. six 
months 
-9.739 -11.527 -7.952 <0.001 
six weeks vs. one 
year 
-18.962 -21.063 -16.861 <0.001 
six months vs. one 
year 
-9.222 -10.766 -7.679 <0.001 
Adjustment for multiple comparisons: Least Significant Difference  
3.3.2 Analysis of the sub scores of the Constant Score 
3.3.2.1 Activities of Daily Living (ADL) 
A repeated measures ANOVA did not show a significant difference in the 
Constant ADL Score between treatment groups (p=0.85) but did show a 
significant difference between time intervals (p<0.001). There was no significant 
difference between the profile of recovery between the three treatment groups 
(p=0.85). 
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However, a further analysis using a pairwise comparison allowed the 
intercomparison of the individual treatment groups. The Exercise Class showed 
a significantly better ADL score than the Multimodal and the Home Exercise 
Groups (p=0.037, p<0.001) respectively. The Multimodal Group showed a 
significantly better ADL score than the Home Exercise Group (p=0.041)(Table 
3.4).  
 
Table 3.4 Pairwise comparison between overall means of the different 
treatment groups of the Constant ADL Score.  
Pairwise Comparison Mean 
Difference 
Standard Error p value 
Exercise Class vs. 
Multimodal 
1.452 0.680 0.037 
Exercise Class vs. 
Home Exercises 
2.840 0.681 <0.001 
Multimodal vs.  
Home Exercises 
 
1.388 0.696 0.041 
Adjustment for multiple comparisons: Least Significant Difference  
 
A pairwise comparison showed a significant difference in the Constant ADL 
Score between six weeks and six months (p<0.001), six weeks and one year 
(p<0.001) and between six months and one year (p<0.001)(Table 3.5). This 
shows a continued improvement over time, Figure 3.2. 
 
Table 3.5 Pairwise comparison between the different time intervals of the 
Constant ADL Score.  
Pairwise Comparison Mean 
Difference 
95%confidence 
interval for mean 
difference 
p value 
Lower 
Bound 
Upper 
Bound 
six weeks vs. six 
months 
-1.982 -2.653 -1.312 <0.001 
six weeks vs. one 
year 
-3.041 -3.694 -2.388 <0.001 
six months vs. one 
year 
-1.059 -1.560 -0.558 <0.001 
Adjustment for multiple comparisons: Least Significant Difference  
41 
 
3.3.2.2 Range Of Movement (ROM) 
A repeated measures ANOVA did not show a significant difference in the 
Constant ROM Score between treatment groups (p=0.37) but did show a 
significant difference between time intervals (p<0.001). There was no significant 
difference between the profile of recovery between the three treatment groups 
(p=0.37). 
 
However, a further analysis using a pairwise comparison allowed the 
intercomparison of the individual treatment groups. The Exercise Class showed 
a significantly better Constant ROM Score than the Multimodal and the Home 
Exercise Groups (p=0.020, p<0.001) respectively. The Multimodal Group 
showed a significantly better Constant ROM Score than the Home Exercise 
Group (p=0.009)(Table 3.6).  
 
Table 3.6 Pairwise comparison between overall means of the different 
treatment groups for the Constant ROM Score. 
Pairwise Comparison Mean 
Difference 
Standard Error p value 
Exercise Class vs. 
Multimodal 
 
 
2.131 
 
0.888 
 
0.020 
Exercise Class vs. 
Home Exercises 
 
 
4.615 
 
0.893 
 
<0.001 
Multimodal vs.  
Home Exercises 
 
 
2.485 
 
0.917 
 
0.009 
Adjustment for multiple comparisons: Least Significant Difference  
 
A pairwise comparison showed a significant difference in the Constant ROM 
Score between six weeks and six months (p<0.001), six weeks and one year 
(p<0.001) and between six months and one year (p<0.001)(Table 3.7). This 
shows a continued improvement over time, Figure 3.2. 
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Table 3.7 Pairwise comparison between the different time intervals for the 
Constant ROM Score.  
Pairwise Comparison Mean 
Difference 
95% Confidence 
Interval for Mean 
Difference 
p value 
Lower 
Bound  
Upper 
Bound 
six weeks vs. six 
months 
-1.502 -2.262 -0.742 <0.001 
six weeks vs. one 
year 
-3.490 -4.225 -2.755 <0.001 
six months vs. one 
year 
-1.988 -2.728 -1.248 <0.001 
Adjustment for multiple comparisons: Least Significant Difference  
3.3.2.3 Pain 
A repeated measures ANOVA did not show a significant difference in the 
Constant Pain Score between treatment groups (p=0.117) but did show a 
significant difference between different time intervals (p<0.001). There was no 
significant difference between the profile of recovery between the three 
treatment groups (p=0.117). 
 
However, a further analysis using a pairwise comparison allowed the 
intercomparison of the individual treatment groups. The Exercise Class showed 
a significantly better pain score than the Multimodal and the Home Exercise 
Groups (p=0.008, p<0.001) respectively. The Multimodal Group did not show a 
significantly better pain score than the Home Exercise Group (p=0.075)(Table 
3.8).  
 
Table 3.8 Pairwise comparison between overall means of the different 
treatment groups for the Constant Pain Score. 
Pairwise Comparison Mean 
Difference 
Standard Error p value 
Exercise Class vs. 
Multimodal 
4.172 1.512 0.008 
Exercise Class vs. 
Home Exercises 
7.059 1.568 <0.001 
Multimodal vs.  
Home Exercises 
2.887 1.593 0.075 
Adjustment for multiple comparisons: Least Significant Difference  
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A pairwise comparison showed a significant difference in the Constant Pain 
Score between six weeks and six months (p<0.001), six weeks and one year 
(p<0.001) and between six months and one year (p<0.001)(Table 3.9). This 
shows a continued improvement over time, Figure 3.2. 
 
Table 3.9 Pairwise comparison between the different time intervals for the 
Constant Pain Score. 
Pairwise Comparison Mean 
Difference 
95% Confidence 
Interval for Mean 
Difference 
p value 
Lower 
Bound 
Upper 
Bound 
six weeks vs. six 
months 
-4.007 -5.206 -2.808 <0.001 
six weeks vs. one 
year 
-7.750 -9.027 -6.473 <0.001 
six months vs. one 
year 
-3.743 -4.685 -2.800 <0.001 
Adjustment for multiple comparisons: Least Significant Difference  
3.3.2.4 Strength 
A repeated measures ANOVA showed a significant difference in the Constant 
Strength Score between treatment groups (p<0.001) and between different time 
intervals (p<0.001). There was a significant difference between the profile of 
recovery between the three treatment groups (p<0.001). 
 
However, a further analysis using a pairwise comparison allowed the 
intercomparison of the individual treatment groups. The Exercise Class showed 
a significantly better Strength score than the Multimodal and the Home Exercise 
Groups (p<0.001, p<0.001) respectively. The Multimodal Group showed a 
significantly better Strength score than the Home Exercise Group 
(p=0.006)(Table 3.10).  
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Table 3.10 Pairwise comparison between overall means of the different 
treatment groups for the Constant Strength Score.  
Pairwise Comparison Mean 
Difference 
Standard Error p value 
Exercise Class vs. 
Multimodal 
3.228 0.740 <0.001 
Exercise Class vs. 
Home Exercises 
5.391 0.731 <0.001 
Multimodal vs.  
Home Exercises 
2.163 0.753 
 
 0.006 
Adjustment for multiple comparisons: Least Significant Difference  
A pairwise comparison showed a significant difference in the Constant Strength 
Score between six weeks and six months (p<0.001), six weeks and one year 
(p<0.001) and between six months and one year (p<0.001)(Table 3.11). This 
shows a continued improvement over time, Figure 3.2. 
 
Table 3.11 Pairwise comparison between the different time intervals for the 
Constant Strength Score.  
Pairwise Comparison Mean 
Difference 
95% Confidence 
Interval for Mean 
Difference 
p value 
Lower 
Bound 
Upper 
Bound 
six weeks vs. six 
months 
-2.164 -2.845 -1.482 <0.001 
six weeks vs. one 
year 
-4.685 -5.502 -3.868 <0.001 
six months vs. one 
year 
-2.521 -3.144 -1.899 <0.001 
Adjustment for multiple comparisons: Least Significant Difference  
 
3.4 ANALYSIS OF THE OXFORD SHOULDER SCORE (OSS) 
 
3.4.1 Analysis of the Oxford Shoulder Score between the different time 
intervals and treatment groups 
Figure 3.3 shows the mean values of the Oxford Shoulder Score. This is a 
subjective questionnaire which contains 12 questions. This is derived from two 
parameters; pain and function. Scores from each of the questions are added to 
produce a single score with a range from 12 (least difficulties) to 60 (most 
difficulties).  
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Figure 3.3 Mean Oxford Shoulder Score value for each treatment group at six 
weeks, six months and at one year for the Oxford Shoulder Score. 
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A repeated measures ANOVA showed a significant difference in the Oxford 
Shoulder Score between treatment groups (p<0.001) and between different 
time intervals (P = 0.033). There was a significant difference between the profile 
of recovery between the three treatment groups (p<0.001). 
 
However, a further analysis using a pairwise comparison allowed the 
intercomparison of the individual treatment groups. The Exercise Class showed 
a significantly better Oxford Shoulder Score than the Multimodal and the Home 
Exercise Groups (p<0.037, p<0.001) respectively. The Multimodal Group 
showed a significantly better Oxford Shoulder Score than the Home Exercise 
Group (p<0.001)(Table 3.12). 
   
Table 3.12 Pairwise comparison between overall means of the different 
treatment groups for the Oxford Shoulder Score. 
Pairwise Comparison Mean 
Difference 
Standard Error p value 
Exercise Class vs. 
Multimodal 
-2.848* 1.332 0.037 
Exercise Class vs. 
Home Exercises 
-7.549* 1.316 <0.001 
Multimodal vs.  
Home Exercises 
-4.701* 1.347 <0.001 
Adjustment for multiple comparisons: Least Significant Difference  
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A pairwise comparison showed a significant difference in the Oxford Shoulder 
Score between six weeks and six months (p<0.001), six weeks and one year 
(p<0.001) and between six months and one year (p<0.001)(Table 3.13). This 
shows a continued improvement over time, Figure 3.3. 
 
Table 3.13 Pairwise comparison between the different time intervals for the 
Oxford Shoulder Score. 
 
Pairwise Comparison Mean 
Difference 
95% Confidence 
Interval for Mean 
Difference 
p value 
Lower 
Bound 
Upper 
Bound 
six weeks vs. six 
months 
5.162 3.957 6.366 <0.001 
six weeks vs. one 
year 
9.504 8.386 10.622 <0.001 
six months vs. one 
year 
4.342 3.141 5.544 <0.001 
 
 
Adjustment for multiple comparisons: Least Significant Difference  
 
3.4.2 Analysis of the sub scores of the Oxford Shoulder Score 
3.4.2.1 Pain 
A repeated measures ANOVA showed a significant difference in the Oxford 
Pain Score between treatment groups (p<0.001) and between different time 
intervals (P = 0.015). There was a significant difference between the profile of 
recovery between the three treatment groups (p<0.001). 
 
However, a further analysis using a pairwise comparison allowed the 
intercomparison of the individual treatment groups. The Exercise Class showed 
a significantly better Pain score than the Multimodal and the Home Exercise 
Groups (p=0.004, p<0.001) respectively. The Multimodal Group showed a 
significantly better Pain score than the Home Exercise Group (p<0.001)(Table 
3.14). 
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Table 3.14 Pairwise comparison between overall means of the different 
treatment groups for the Oxford Pain Score. 
Pairwise Comparison Mean 
Difference 
Standard Error p value 
Exercise Class vs. 
Multimodal 
-1.825 0.615 0.004 
Exercise Class vs. 
Home Exercises 
-4.152 0.606 <0.001 
Multimodal vs.  
Home Exercises 
-2.327 0.624 <0.001 
Adjustment for multiple comparisons: Least Significant Difference  
 
A pairwise comparison showed a significant difference in the Oxford Pain Score 
between six weeks and six months (p<0.001), six weeks and one year 
(p<0.001) and between six months and one year (p<0.001)(Table 3.15). This 
shows a continued improvement over time, Figure 3.3. 
 
Table 3.15 Pairwise comparison between the different time intervals for the 
Oxford Pain Score. 
Pairwise Comparison Mean 
Difference 
95% Confidence 
Interval for Mean 
Difference 
p value 
Lower 
Bound 
Upper 
Bound 
six weeks vs. six 
months 
2.931 2.313 3.550 <0.001 
six weeks vs. one 
year 
5.230 4.586 5.875 <0.001 
six months vs. one 
year 
2.299 1.746 2.853 <0.001 
 
Adjustment for multiple comparisons: Least Significant Difference  
3.4.2.2 Function 
A repeated measures ANOVA showed a significant difference in the Oxford 
Function Score for function between treatment groups (p=0.012) but not 
between different time intervals (P = 0.090). There was a significant difference 
between the profile of recovery between the three treatment groups (p=0.012). 
 
However, a further analysis using a pairwise comparison allowed the 
intercomparison of the individual treatment groups. The Exercise Class did not 
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show a significantly better Function score than the Multimodal Group (p=0.360) 
but the Exercise Class showed a significantly better Function score than the 
Home Exercise Group (p<0.001). The Multimodal Group showed a significantly 
better Function score than the Home Exercise Group (p=0.006)(Table 3.16).  
 
Table 3.16 Pairwise comparison between overall means of the different 
treatment groups for the Oxford Function Score. 
Pairwise Comparison Mean 
Difference 
Standard Error p value 
Exercise Class vs. 
Multimodal 
-0.796 0.862 0.360 
Exercise Class vs. 
Home Exercises 
-3.262 0.851 <0.001 
Multimodal vs.  
Home Exercises 
-2.467 0.872 0.006 
Adjustment for multiple comparisons: Least Significant Difference  
A pairwise comparison showed a significant difference in the Oxford Function 
Score between six weeks and six months (p<0.001), six weeks and one year 
(p<0.001) and between six months and one year (p<0.001)(Table 3.17). This 
shows a continued improvement over time, Figure 3.3. 
 
Table 3.17 Pairwise comparison between the different time intervals for the 
Oxford Function Score. 
Pairwise Comparison Mean 
Difference 
95% Confidence 
Interval for Mean 
Difference 
p value 
Lower 
Bound 
Upper 
Bound 
six weeks vs. six 
months 
2.383 1.578 3.188 <0.001 
six weeks vs. six 
year 
4.425 3.626 5.228 <0.001 
six months vs. one 
year 
2.042 1.229 2.856 <0.001 
 
Adjustment for multiple comparisons: Least Significant Difference  
49 
 
3.5 ANALYSIS OF THE HOSPITAL ANXIETY AND DEPRESSION SCALE 
(HADS)  
HADS consists of seven depressive items measuring cognitive and emotional 
aspects of depression (HADS-D) and seven anxiety items focusing on 
emotional aspects of anxiety (HADS-A). This score consists of 14 items rated 
on a four-point scale, ranging from the absence of a symptom or the presence 
of positive features (scoring 0) to maximal symptomology or the absence of 
positive features, which score three. Therefore, the higher the score the more 
severe the disorder, indicating greater severity.  
3.5.1 Analysis of the HADS for Anxiety (HADS-A) between the different 
time intervals and treatment groups  
Figure 3.4 Mean HADS-A value for each treatment group at six weeks, 
six months and at one year for the HADS-A. 
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 A repeated measures ANOVA showed a significant difference in the HADS-A 
Score between treatment groups (p<0.001) but did not show a significant 
difference between different time intervals (p=0.566). There was a significant 
difference between the profile of recovery between the three treatment groups 
(p<0.001). 
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However, a further analysis using a pairwise comparison allowed the 
intercomparison of the individual treatment groups. The Exercise Class did not 
show a significantly better HADS-A score than the Multimodal Group (p=0.288). 
However, the Exercise Class showed a significantly better HADS-A score than 
the Home Exercise Group (p<0.001) and the Multimodal Group showed a 
significantly better HADS-A score than the Home Exercise Group 
(p=0.024)(Table 3.18).    
   
Table 3.18 Pairwise comparison between overall measures of the different 
treatment groups for the HADS-A. 
Pairwise Comparison Mean 
Difference 
Standard Error p value 
Exercise Class vs. 
Multimodal 
-0.686 0.639 0.288 
Exercise Class vs. 
Home exercise 
-2.195 0.636 <0.001 
Multimodal vs.  
Home Exercises 
-1.509 0.653 0.024 
Adjustment for multiple comparisons: Least Significant Difference  
A pairwise comparison did not show a significant difference in the HADS-A 
Score between six weeks and six months (p=0.442), six weeks and one year 
(p=0.231) but did show a significant difference between six months and one 
year (p=0.035)(Table 3.19). This shows a continued improvement over time, 
Figure 3.4. 
 
Table 3.19 Pairwise comparison between the different time intervals for the 
HADS-A.  
Pairwise Comparison Mean 
Difference 
95% Confidence 
Interval for Mean 
Difference 
p value 
Lower 
Bound 
Upper 
Bound 
six weeks vs. six 
months 
-0.243 -0.871 0.385 0.442 
six weeks vs. one 
year 
0.431 -0.281 1.143 0.231 
six months vs. one 
year 
0.674 0.050 1.298 0.035 
Adjustment for multiple comparisons: Least Significant Difference  
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3.5.2 Analysis of the HADS for Depression (HADS-D) between the different 
time intervals and treatment groups 
 
Figure 3.5 Mean HADS-D value for each treatment group at six weeks, six 
months and at one year for the HADS-D. 
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A repeated measures ANOVA did not show a significant difference in the 
HADS-D between treatment groups (p=0.359) or between different time 
intervals (p=0.750). There was not a significant difference between the profile of 
recovery between the three treatment groups (p=0.359). 
 
However, a further analysis using a pairwise comparison allowed the 
intercomparison of the individual treatment groups. The Exercise Class did not 
show a significantly better HADS-D score than the Multimodal Group (p=0.704). 
However, the Exercise Class showed a significantly better HADS-D score than 
the Home Exercise Group (p=0.006) and the Multimodal Group showed a 
significantly better HADS-D score than the Home Exercise Group 
(p=0.021)(Table 3.20).   
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Table 3.20 Pairwise comparison between overall means of the different 
treatment groups for the HADS-D. 
Pairwise Comparison Mean 
Difference 
Standard Error p value 
Exercise Class vs. 
Multimodal 
-0.173 0.453 0.704 
Exercise Class vs. 
Home Exercises 
-1.264 0.447 0.006 
Multimodal vs.  
Home Exercises 
-1.090 0.458 0.021 
Adjustment for multiple comparisons: Least Significant Difference  
A pairwise comparison did not show a significant difference in the HADS-D 
between six weeks and six months (p=0.208) and between six months and one 
year (p=0.068), but did show a significant difference between six weeks and 
one year (p=0.014)(Table 3.21). This shows a continued improvement over 
time, Figure 3.5. 
 
Table 3.21 Pairwise comparison between the different time intervals for the 
HADS-D. 
Pairwise Comparison Mean 
Difference 
95% Confidence 
Interval for Mean 
Difference 
p value 
Lower 
Bound 
Upper 
Bound 
six weeks vs. six 
months 
0.285 -0.163 0.732 0.208 
six weeks vs. one 
year 
 0.731 0.151 1.311 0.014 
six months vs. one 
year 
0.446 -0.034 0.927 0.068 
 
Adjustment for multiple comparisons: Least Significant Difference  
 
3.6 ANALYSIS OF THE SHORT FORM 36 (SF-36) 
 
The short form 36 item health survey (SF-36) is a widely used, self 
administered, 36 item generic indicator of health status which consists of eight 
subscales representing eight dimensions of quality of life: general health 
perceptions (GH), physical function (PF), role limitations because of physical 
health problems (RP), role limitations because of emotional problems (RE), 
social functioning (SF), bodily pain (BP), vitality (VT) and general mental health 
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(MH). Each of the eight subscales is rescaled from 0–100; higher scores 
represent better health.  
3.6.1 Analysis of the SF-36 between the different time intervals and 
treatment groups 
3.6.1.1 General Health (GH)     
A repeated measures ANOVA did not show a significant difference in the GH 
between treatment groups (p=0.937) or between different time intervals 
(p=0.223). There was not a significant difference between the profile of recovery 
between the three treatment groups (p=0.937). 
3.6.1.2 Physical Function (PF)  
A repeated measures ANOVA did not show a significant difference in the PF 
between treatment groups (p=0.470) or between different time intervals 
(p=0.674). There was not a significant difference between the profile of recovery 
between the three treatment groups (p=0.470). 
3.6.1.3 Role limitations because of health problems (RP) 
A repeated measures ANOVA did not show a significant difference in the RP 
between treatment groups (p=0.354) or between different time intervals 
(p=0.132). There was not a significant difference between the profile of recovery 
between the three treatment groups (p=0.354). 
3.6.1.4 Role limitations because of emotional problems (RE) 
A repeated measures ANOVA did not show a significant difference in the RE 
between treatment groups (p=0.843) or between different time intervals 
(p=0.300). There was not a significant difference between the profile of recovery 
between the three treatment groups (p=0.843). 
3.6.1.5 Social Functioning (SF) 
A repeated measures ANOVA did not show a significant difference in the SF 
between treatment groups (p=0.335) but did show a significant difference in the 
time intervals (p<0.001). There was not a significant difference between the 
profile of recovery between the three treatment groups (p=0.335). 
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However, a further analysis using a pairwise comparison allowed the 
intercomparison of the individual treatment groups. The Exercise Class did not 
show a significantly better SF score than the Multimodal or the Home Exercise 
Groups (p=0.882, p=0.227) respectively. The Multimodal Group did not show a 
significantly better SF score than the Home Exercise Group (p=0.306)(Table 
3.22).  
 
Table 3.22 Pairwise comparison between overall means of the different 
treatment groups for SF. 
Pairwise Comparison Mean 
Difference 
Standard Error p value 
Exercise Class vs. 
Multimodal 
0.806 5.397 0.882 
Exercise Class vs. 
Home Exercises 
6.539 5.356 0.227                
Multimodal vs.  
Home Exercises 
5.733 5.549 0.306 
Adjustment for multiple comparisons: Least Significant Difference  
 
A pairwise comparison did not show a significant difference in the SF between 
six weeks and six months (p=0.844), but did show a significant difference 
between six weeks and one year (p=0.045) and between six months and one 
year (p=0.021)(Table 3.23). This shows a continued improvement over time. 
 
Table 3.23 Pairwise comparison between the different time intervals for SF. 
Pairwise Comparison Mean 
Difference 
95% Confidence 
Interval for Mean 
Difference 
p value 
Lower 
Bound 
Upper 
Bound 
six weeks vs. six 
months 
-0.386 -4.293 3.521 0.844 
six weeks vs. one 
year 
7.767 0.161 15.372 0.045 
six months vs. one 
year 
8.153 1.249 15.058 0.021 
Adjustment for multiple comparisons: Least Significant Difference  
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3.6.1.6 Bodily Pain (BP) 
A repeated measures ANOVA did not show a significant difference in the BP 
between treatment groups (p=0.520) but did show a significant difference 
between different time intervals (p=0.011). There was not a significant 
difference between the profile of recovery between the three treatment groups 
(p=0.520). 
 
However, a further analysis using a pairwise comparison allowed the 
intercomparison of the individual treatment groups. The Exercise Class did not 
show a significantly better BP score than the Multimodal Group (p=0.122) and 
the Multimodal Group did not show a significantly better BP score than the 
Home Exercise Group (p=0.525). However, the Exercise Class did show a 
significantly better BP score than the Home Exercise Group (p=0.032)(Table 
3.24).  
 
Table 3.24 Pairwise comparison between overall means of the different 
treatment groups for BP.  
Pairwise Comparison Mean 
Difference 
Standard Error p value 
Exercise Class vs. 
Multimodal 
8.310 5.302 0.122 
Exercise Class vs. 
Home Exercises 
11.772 5.355 0.032                
Multimodal vs.  
Home Exercises 
3.462 5.411 0.525 
Adjustment for multiple comparisons: Least Significant Difference  
A pairwise comparison did not show a significant difference in the BP between 
six weeks and six months (p=0.938), but did show a significant difference 
between six weeks and one year (p<0.001) and between six months and one 
year (p=0.005)(Table 3.25). This shows a continued improvement over time. 
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Table 3.25 Pairwise comparison between the different time intervals for BP.  
Pairwise Comparison Mean 
Difference 
95% Confidence 
Intervals for Mean 
Difference 
p value 
Lower 
Bound 
Upper 
Bound 
six weeks vs. six 
months 
-0.157 -4.165 3.851 0.938 
six weeks vs. one 
year 
-7.189 -11.317 -3.060 <0.001 
six months vs. one 
year 
-7.032 11.862 -2.202 0.005 
Adjustment for multiple comparisons: Least Significant Difference  
3.6.1.7 Vitality (VT) 
A repeated measures ANOVA did not show a significant difference in the VT 
between treatment groups (p=0.384) or between different time intervals 
(p=0.825). There was not a significant difference between the profile of recovery 
between the three treatment groups (p=0.384). 
3.6.1.8 Mental Health (MH) 
A repeated measures ANOVA did not show a significant difference in the MH 
between treatment groups (p=0.075) but did show a significant difference 
between different time intervals (p=0.009). There was not a significant 
difference between the profile of recovery between the three treatment groups 
(p=0.075). 
 
However, a further analysis using a pairwise comparison allowed the 
intercomparison of the individual treatment groups. The Exercise Class did not 
show a significantly better MH score than the Multimodal or the Home Exercise 
Groups (p=0.059, p=0.126) respectively. The Multimodal Group did not show a 
significantly better MH score than the Home Exercise Group (p=0.705)(Table 
3.26).  
 
57 
 
Table 3.26 Pairwise comparison between overall means of the different 
treatment groups for MH.  
Pairwise Comparison Mean 
Difference 
Standard Error p value 
Exercise Class vs. 
Multimodal 
6.313 3.274 0.059 
Exercise Class vs. 
Home Exercises 
5.056 3.256 0.126 
Multimodal vs.  
Home Exercises 
-1.257 3.300 0.705 
Adjustment for multiple comparisons: Least Significant Difference  
A pairwise comparison did not show a significant difference in the MH between 
six weeks and six months (p=0.815), between six weeks and one year 
(p=0.164) and between six months and one year (p=0.062)(Table 3.27). This 
did show a continued improvement over time. 
 
Table 3.27 Pairwise comparison between the different time intervals for MH.  
Pairwise Comparison Mean 
Difference 
95% Confidence 
Intervals for Mean 
Difference 
p value 
Lower 
Bound 
Upper 
Bound 
six weeks vs. six 
months 
0.272 -2.041 2.584 0.815 
six weeks vs. one 
year 
-2.390 -5.781 1.001 0.164 
six months vs. one 
year 
-0.2.662 0.062 -5.457 0.062 
Adjustment for multiple comparisons: Least Significant Difference  
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3.7 SUMMARY OF RESULTS 
 
The following table outlines the final results. 
Table 3.28 Summary of Results 
 
 
6 WEEKS 6 MONTHS 1 YEAR 
EC M HE EC M HE EC M HE 
CONSTANT 
SCORE 
1 2 3 1 2 3 1 2 3 
 
OSS 
1 2 3 1 2 3 1 2 3 
 
HADS-A 
1 2 3 1 2 3 2 1 3 
 
HADS-D 
1 2 3 1 2 3 2 1 3 
 
Key 
EC = Exercise Class 
M = Multimodal 
HE = Home Exercises 
 
 
 
 
1 
  
1 
 
2 
  
1 
 
3 
  
1 
Most Effective 
Moderately Effective 
Least Effective 
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Chapter 4 DISCUSSION 
 
4.1 INTRODUCTION 
 
 
This chapter will firstly evaluate and discuss the results obtained in the present 
study. When possible, comparison with other research trials is considered to 
demonstrate the similarities and differences in findings. This chapter will then 
focus on the strengths and limitations in the methods and other relevant issues, 
in order to highlight factors that may have influenced results. Finally statements 
about the experimental hypotheses, clinical implications and suggestions for 
future research will be made.  
 
Despite considerable research and interest in the condition, frozen shoulder 
remains a controversial and debatable disease. Currently, no standard medical, 
surgical, or therapy regimen is universally accepted as the most efficacious 
treatment for restoring motion in patients with frozen shoulder (Loew et al 
2005). Goals of treatment are to decrease pain, increase range of movement 
(ROM) and improve function. Although the literature lacks a consensus on the 
optimal non-operative approach for the treatment of frozen shoulder, it is still the 
primary intervention (Lynch 2002). When this fails, operative treatment of 
manipulation under anaesthetic alone or in combination with arthroscopic 
release may be reasonable options and appear to produce satisfactory results 
in most cases (Hannafin and Chiaia 2000; Hannafin and Strickland 2000). 
 
4.2 LIMITATIONS OF THE STUDY 
 
A potential limitation of the study is the sample size. The pre study sample size 
calculation suggested that 44 patients were required per group to detect a 
clinically significant difference of 15 points on the Constant score, assuming a 
standard deviation of 20 points. The significant difference observed in this study 
was 20 points on the Constant score and the smallest difference of 9.6 points 
on the Constant score. However, the largest standard deviation observed was 
14 points and the smallest standard deviation was 8 points. Based on the 
results of this study a further power calculation was performed. This indicated 
that a lower sample size of 31 per group is required to determine a difference. 
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This reduction in sample size was due to smaller standard deviations that were 
initially estimated which reduces the chance of type 1 errors. The results show 
that there were by chance an unequal number of people with diabetes in each 
group (See Table 3.1). Group two had a considerably greater number than the 
other two groups (Group two – nine, Group one and Group three - two). It could 
be reasonable to suggest that the people with diabetes may have a different 
response to treatment (Smith et al 2003). Unfortunately it would be difficult to 
postulate the overall effect of this imbalance in numbers although it would be 
interesting to understand the implications of this in the future. 
 
Physiotherapy interventions were devised and based on the best evidence 
available and physiotherapists were selected with over sixteen years clinical 
experience in the treatment of musculoskeletal conditions. They specialised in 
the treatment of shoulder disorders for the past nine years. It was not possible 
to standardise all aspects of the physiotherapy intervention in Group two but 
there were common components that could be reproduced in a variety of clinical 
settings. The physiotherapist in this group had over 18 year‟s clinical experience 
and specialised in the treatment of shoulder disorders for the past eleven years. 
The content of each physiotherapy session may have varied from one patient to 
another. It included Maitland mobilisations, which were progressed as the 
condition improved, soft tissue massage, myofascial trigger point release, heat, 
stretches and the identical home exercise programme as given to each of the 
other groups. The scope of generalisabiltiy of the results in the study may be 
limited. Foster et al (2009) reported that RCT‟s are performed to limit individual 
variation and optimize prognostic similarity of intervention groups by using 
homogenous groups of patients. They agree that this limits the generalisability 
of the findings and obscure a variation of individual responses, with some 
patients showing dramatic improvement while others hardly respond to the 
same intervention. While the results cannot be generalised to other types of 
physiotherapy interventions, they apply to patients meeting the selection criteria 
and for the actual interventions in the study. Further research is required to 
verify the effects of various techniques in manual therapy for the treatment of 
frozen shoulder.  
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One year follow up was a relatively short period for a study; especially of a 
disease that many authors suggest has a protracted course and even state can 
last for as long as seven years (Shaffer et al 1992). Symptom resolution does 
not always occur but persistent symptoms are most commonly mild (Hand et al 
2007). The obvious preference would be to continue the study for a prolonged 
time period to investigate if significant numbers of people have residual clinical 
detectable restriction of movement and smaller numbers have residual 
disability. Foster et al (2009) suggest that there has been insufficient 
identification of important patient subgroups in previous trials and simply small 
and often short-term effects have been reported. They recommend that 
outcome measures should be used to assess common musculoskeletal 
conditions over a prolonged time period rather than focusing on specified follow-
up time points alone. Even though this study is relatively short compared to the 
course of the condition, the follow up length of one year is impressive in the 
current state of research in physiotherapy for the treatment of frozen shoulder. 
 
4.3 LIMITATIONS OF THE PRIMARY OUTCOME MEASURE – The Constant 
Score. 
 
To date, research has not identified a specific outcome tool or specified score 
range that is optimal for individuals with frozen shoulder (Kelly et al 2009). Even 
though the Constant score is currently the outcome measure recommended by 
the European Society for Surgery of the Shoulder and the Elbow and by the 
British Elbow and Shoulder Society (Walton et al 2007) but none the less, like 
many outcome measures, it has limitations when applied to frozen shoulder. 
The Constant score lacked the disability and ROM evaluation required for stage 
three of frozen shoulder. It appeared to be more widely used in medical papers 
as a single system of gathering different categories of information. It has a 
maximum score of 100 points with subject parameter of pain and objective 
parameter of ROM and strength components in a ratio of 35:65 (Constant and 
Murley 1987). It uses point systems of different values assigned to pain and 
active ROM after initial goniometry measurement of elevation and lateral 
rotation determined by positions relative to anatomical landmarks. The process 
of assigning score values after goniometry measurement appears unnecessary 
since goniometry measurement has higher validity and reliability than a scoring 
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system (Mayerson and Milano 1984). The procedure for measuring shoulder 
elevation is also vague. Strength is assessed according to the load that can be 
lifted up to a max score of 25 for each pound lifted. One of the most critized 
issues of the Constant score is the relatively high rating of the factor strength on 
the final results (Brinker et al 2002). The limitation of this strength measurement 
is that extra points are not given for strength beyond 25 pounds.  
 
The content of the Constant score appears to include all relevant aspects of 
shoulder outcome, with the exception of whether or not the patient is satisfied 
with his or her shoulder. However, each item of the scale requires a significant 
degree of interpretation by the patient. There is only one pain scale in which the 
patient is asked to rate the most severe pain experienced at rest, during sleep, 
or with various activities. Clinical experience seems to suggest that patients 
experience varying degrees of pain with different activities. One pain scale 
appears to be inadequate to gain a true picture of the patient‟s pain. There is 
also concern that report of function is not specific to any particular activity and 
therefore is left to interpretation by the patient.  
 
The objective assessment of external rotation is also questionable (Gerber 
1993). The patient is awarded four points for placing the hand behind the back 
with the elbow held back, whereas eight points are awarded for hand placement 
on top of the head with the elbow held back. The difference of shoulder external 
rotation between these two points is negligible. 
 
4.4 THE EFFECT BETWEEN THE THREE TREATMENTS 
 
4.4.1 Shoulder Scores (Constant Score; Oxford Shoulder Score [OSS]) 
Both the Constant score and the OSS showed a significant difference between 
the three groups. The Constant score for the Exercise Class showed a 
significant difference in improvement compared to the Home Exercise Group 
and Multimodal Group  (p<0.001). There was a difference between the Exercise 
Class and Home Exercise Group of 33% on the Constant score with the 
Exercise Class having a more positive outcome. This was also apparent 
between the Exercise Class and the Multimodal Group with a difference of 15%. 
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The Multimodal Group also showed an improvement of 15% over the Home 
Exercise Group (p=0.002). 
 
This was also mirrored for the OSS. The Exercise Class showed a significant 
difference in improvement than the Multimodal and Home Exercise Group 
(p=0.037, p<0.001) respectively. There was a difference between the Exercise 
Class and Home Exercise Group and Multimodal Group of 63% on the OSS 
with the Exercise Class again having a more positive outcome. Again the 
Multimodal Group showed an improvement over the Home Exercise Group of 
29% (p<0.001). 
 
The Constant score and the OSS agree and convincingly demonstrate that 
patients in the Exercise Class improve more than patients treated with 
physiotherapy or those doing a home exercise programme. This demonstrates 
a link between exercises in a controlled environment and it appears that a close 
therapist/relationship leads to more adherence. This has been supported by 
Martin et al (1984) and Knapp (1988) who found that in healthy sedentary adults 
whose compliance is being monitored and who received feedback about their 
efforts and progress comply better than adults without supervision. Martin et al 
(1984) concluded that the most reliable measure of adherence was class 
attendance. 
 
Bird and Thornes (1998) recommended that the venue of the class is non-
threatening, that the patients have common agreed goals and collective 
aspirations. Self-efficacy is likely to be increased if new patients can see other 
people actually participating and have had a positive experience from the class. 
Health professionals should give lots of verbal encouragement at the start of a 
new exercise programme, ensuring that unconditional positive reinforcement is 
given during the sessions. Exercising with patients who have similar problems 
can provide peer support, encouragement, reassurance and camaraderie. It is 
also more economically effective if the physiotherapist is able to supervise 
several people at once.  
 
Smidt et al (2005) concluded in their systematic review, that there was 
insufficient evidence to support or refute the effectiveness of therapeutic 
64 
 
exercise for shoulder pain. However, the results of this study contradict this and 
agree with the findings by Brosseau et al (2004) and Pelland et al (2004) that 
supervised group exercise programmes were more effective than unsupervised 
individual exercise programmes in treating osteoarthritis of the knee.  
 
4.4.2 Psychosocial Scores (Hospital Anxiety and Depression Scale 
[HADS]; Short Form 36 item health survey [SF-36]) 
HADS-A results further showed that there was a significant difference in 
improvement between the Exercise Class and Home Exercise Group (p<0.001).  
The patients in the Exercise Class Group had a lower level of anxiety than 
those in the Home Exercise Group measured as a 40% difference on the 
HADS-A. The Multimodal Group showed a significantly better HADS-A score 
than the Home Exercise Group (p=0.024), with an improvement of 27%. When 
comparing the Exercise Class Group against the Multimodal Group there was 
no significant difference, however a mean improvement of 17% was seen 
(p=0.288) which could be a clinically important difference. Therefore, this could 
suggest that patients are less anxious when there is an intervention from a 
physiotherapist, be it from the Exercise Class Group or the Multimodal Group 
and that the patients have benefited from greater positive psychosocial 
influences during treatment.  
 
The HADS-D results also show that there was a significant difference in 
improvement between the Exercise Class and Home Exercise Group (p=0.006). 
The patients in the Exercise Class also had a lower level of depression than 
those in the Home Exercise Group measured as a 35% difference on the 
HADS-D. This is also apparent in the Multimodal Group, showing a 31% 
improvement than the Home Exercise Group (p=0.021). Therefore both groups 
with the presence of a physiotherapist appear to suggest they are less 
depressed than in the Home Exercise Group that have had no intervention. This 
may be due to the fact that in the Exercise Class and Multimodal Group the 
patients are receiving continual feedback about their progress. They will have 
constant reassurance, direction and guidance on the progression of their 
condition and subsequent treatment. Patients may also feel supported as their 
condition is being closely monitored by their physiotherapist and therefore any 
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anxieties that developed may be quickly addressed. There was no significant 
difference between the Exercise Class Group and Multimodal Group.  
 
This study suggests that the use of HADS has identified that physiotherapy 
intervention in a group setting in the management of frozen shoulder, can 
influence the psychological status of a patient in a beneficial way. This is the 
first time that this has been investigated and is therefore a novel finding from 
this study. HADS scores have not been used in any form of research 
appertaining to the treatment of frozen shoulder with this specific form of 
exercise. It has not been possible to find any other physiotherapy studies that 
have been used to compare this to date. There appears to be relatively little 
research into the psychometric properties of the HADS for use in a rehabilitation 
context. One exception is a study conducted by Harter et al (2001). They 
assessed the HADS in a number of inpatient rehabilitation clinics as a screening 
tool with musculoskeletal patients. Based on the findings of their study they 
recommended that the HADS was an efficient instrument to identify patients 
with musculoskeletal disease and potential psychiatric morbidity. More recently, 
Pallant and Bailey (2005) proposed that it is necessary for clinicians who are 
considering using the HADS as a screening tool to first assess its suitability with 
their particular patient group. They found high levels of anxiety and depression 
detected in their sample of 296 patients attending an outpatient musculoskeletal 
clinic and suggested that screening for psychological co-morbidity is important 
in musculoskeletal rehabilitation settings.  
 
4.4.3 SF-36  
The SF-36 had been used to explain either psychological or physical 
relationships which may have had an impact on the outcomes from the 
interventions. Interestingly, out of all components of the SF-36, only the Bodily 
Pain showed any significant change. The Exercise Class showed a significantly 
better Bodily Pain score than the Home Exercise Group (p=0.032). This is more 
closely linked to expected physiotherapy outcomes.  
 
Due to the evidence that the Constant score, OSS and HADS scores have 
shown a definite change and the SF-36 has only demonstrated a minor change 
in one of the subscales, this may suggest that the SF-36 is not an appropriate 
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outcome measure for patients with frozen shoulder as shown from these 
analyses. Interestingly, this is also reported by Carette et al (2003), who found 
that there were no significant differences between the groups they had analysed 
in their study comparing the use of corticosteroid injection, a supervised 
exercise programme and a combination of the two and placebo in the treatment 
of frozen shoulder. Beaton and Richards (1996) and Griggs et al (2000), 
concluded that the SF-36 was not sensitive enough to detect the disability 
experienced by patients with upper extremity problems. Griggs et al (2000) 
incorporated the SF-36 into a study evaluating the efficacy of a specific four-
direction shoulder-stretching exercise programme. They concluded that the SF-
36 did not demonstrate significantly lower scores for the satisfied patients 
compared with the general population. Mossberg and McFarland (1995) were 
also in agreement discovering that there were lower physical functioning scores 
in patients with lower-quarter involvement than those with upper-quarter 
involvement. Buckbinder et al (2004), in a previous trial of oral steroids for 
frozen shoulder, discovered that only the bodily pain subscale of the SF-36 
detected a benefit of prednisolone over placebo at three weeks, despite large 
clinically significant benefits observed for other outcomes including pain, 
function and ROM. This finding suggests that generic measures of quality of life 
such as the SF-36 may not be a useful outcome to measure in clinical trials of 
interventions for frozen shoulder. 
 
This is in contrast to the paper by Paul et al (2004) who recommended using a 
core of health measures to enable comparison between studies and data 
pooling, including a self completed shoulder-specific questionnaire, 10cm VAS 
scores of pain and a generic health measure. The local clinical practice 
recommends that the use of the SF-36 is part of the routine outcome 
assessments in the Upper limb Unit at Wrightington Hospital. However, the 
results of this study tend to concur that the SF-36 is not a good outcome 
measure for patients with a diagnosis of frozen shoulder, given that nearly all 
items in the physical functioning subscale are in some way associated with the 
use of lower extremities. 
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4.5 CHANGE BETWEEN TIME INTERVALS 
 
4.5.1 Shoulder Scores (Constant Score; OSS) 
The Constant score and OSS show that patients treated in all of the three 
groups demonstrated improvement at six weeks, with further improvement at six 
months and still further improvement at one year. This confirms those results 
reported by Reeves (1975), Binder et al (1984) and Shaffer et al (1992) 
suggesting the natural history of frozen shoulder is such that most patients 
improve with time. A similar relationship was seen for all treatments.  
 
4.5.1.1 Constant Score 
In the Exercise Class Group there was a 91% improvement from baseline at six 
weeks, 104% improvement from baseline at six months and 116% improvement 
at one year. In the Multimodal Group there was only 68% improvement from 
baseline at six weeks, 76% improvement at six months and 92% at one year. In 
the Home Exercise Group there was a 41% improvement from baseline at six 
weeks, 58% improvement from baseline at six months and 78% improvement at 
one year. 
 
One would expect a significant change in results during the first six weeks due 
to the impact of treatment intervention. This is indeed reflected in the results of 
this study. In clinical practice we would normally consider a change (MCID) of 
approximately 15 points to be clinically important. The improvement of 91% 
excessively exceeds the MCID, similarly in the Multimodal Group by 68% and 
doubled in the Home Exercise Group by 41%. This may be due to the benefits 
of group exercise. Group exercise provides a clinical setting in which patients 
can discuss their condition with others who are in a similar position. This may 
reassure patients and provide them with peer support and the motivation they 
need to continue and progress their rehabilitation.  
 
At six months there is a smaller effect from the intervention at six weeks, which 
could reflect a gradual improvement due to the natural history of the condition. 
In the long term follow up of one year the MCID is still apparent. The Exercise 
Class Group has 116% improvement, the Multimodal Group has an 
improvement of 92% and the Home Exercise Group has still improved by 78%. 
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Even though there is an enormous improvement in the patients in the first six 
weeks there is a continued improvement up until one year.  
 
4.5.1.2 OSS 
In the Exercise Class Group there was a 40% improvement from baseline at six 
weeks, 55% improvement from baseline at six months and 62% improvement at 
one year. In the Multimodal Group there was only 33% improvement from 
baseline at six weeks, 46% improvement at six months and 54% at one year. In 
the Home Exercise Group there was a 14% improvement from baseline at six 
weeks, 28% improvement from baseline at six months and 51% improvement at 
one year.  
 
Work is in process to produce MCID estimates for the OSS. Currently there is 
no MCID guidelines published. This study demonstrated in the results that the 
Exercise Class Group had a 40% improvement, compared to the Multimodal 
Group of 33% and consistent with all the previous results in this study the Home 
Exercise Group only had a minimal improvement of 14%. This dramatic change 
supports the results of the Constant score with a positive influence after the 
intervention of a physiotherapist in a class or individual treatment.  
 
Again at six months when the intervention was withdrawn, there was minimal 
change. However, the change was not a short term improvement but continued 
up to six months with an improvement of 55% in the Exercise Class Group, 46% 
in the Multimodal Group and only 28% in the Home Exercise Group. The scores 
appear to converge over a 12 month period similar to the Constant score, 
supporting the natural history of frozen shoulder.  
 
Perhaps the reason for the larger improvement of the Constant score rather 
than the OSS is the use of a purely subjective questionnaire. It has not been 
resolved whether this discrepancy between the subjective and objective 
outcome is due to an adaptation to the restriction of ROM or to the fact that the 
restriction of movement are in planes that are unimportant for the activities of 
daily living e.g. lateral rotation in neutral. Neer (1990) suggested that the 
limitation of lateral rotation impacts on the functional demands of the patient. 
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Older patients, who have fewer functional demands, can tolerate more 
restriction in any plane of movement.  
 
The study confirms that the improvement gained during the first six weeks of 
intervention was likely to be due to the intervention itself and not spontaneous 
recovery. After six weeks and therefore following intervention, if spontaneous 
recovery was occurring, a greater improvement between the six weeks and six 
months would have been expected in all three groups. This was not 
demonstrated in the results and may suggest that initial intervention of a 
physiotherapist (Exercise Class Group or Multimodal Group) continued to have 
a positive impact on the patient scores.  
 
Athough several authors consider frozen shoulder to be a self -limiting disorder 
with spontaneous recovery within two years (Lundberg 1969 and Watson-Jones 
1963), most recent articles agree that it is not that predictable. Several authors 
concur that the disability is likely to persist for three or more years (Reeves 
1975 and Shaffer et al 1992). It is difficult to compare this study due to the lack 
of initial investigation for the natural history of frozen shoulder rather than long 
term follow up. Binder et al (1984) performed a prospective study of 40 patients 
to determine the long term outcome of frozen shoulder but did establish that at 
eight month follow up there was significant improvement in all movements of the 
shoulder, although five patients had shown some deterioration of range during 
this time. However, when the range was compared with that in the control group 
significant restriction in range of all movements except shoulder abduction and 
flexion was still present, suggesting that patients had improved but not to a 
normal level. 
 
4.5.2 Psychosocial Scores (HADS; SF-36) 
4.5.2.1 HADS – A    
The results show that there was no significant difference in the scores between 
the groups initially at six weeks but at six months, a significant difference was 
apparent. This may suggest that the patients became less anxious at this point 
and continued up to one year. The postulation may be that the patients‟ anxiety 
status improved and could be due to experiencing less pain, improved ROM 
and function. A possible explanation could be that in accordance with the 
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natural history of frozen shoulder, as time progresses pain becomes less of a 
problem than stiffness and therefore pain scores would naturally decrease. This 
could explain why there was also further pain reduction between six weeks and 
six months. It could be considered that if one had this condition for a long time 
and had short term pain relief, (that is in the first six weeks of intervention) one 
may still be anxious. As time continued and the pain continued to improve as 
the study showed at six months and one year, anxiety would decrease as one 
was more confident that the pain would not return.  
 
In the Exercise Class Group there was a 63% improvement from baseline at six 
weeks, 43% improvement from baseline at six months and no further 
improvement at one year. In the Multimodal Group there was 38% improvement 
from baseline at six weeks, 30% improvement at six months and 52% at one 
year. In the Home Exercise Group there was a 15% improvement from baseline 
at six weeks, 5% improvement from baseline at six months and 27% 
improvement at one year. 
 
These results are inconsistent with the other scores in this study but the general 
pattern of improvement was similar to that seen in the Constant score and the 
OSS. This study provides strong evidence that the Exercise Class Group 
provides the optimum effect of intervention across a number of outcome 
parameters. 
 
4.5.2.2 HADS – D  
The results show that there was a significant difference at six weeks compared 
to one year. This demonstrated a continued improvement over time and 
suggested that with intervention there was some effect on Depression scores. A 
decrease in pain could lead to a patient being less depressed immediately at six 
weeks but it could be quite possible that one would still be anxious until time 
progressed. This may imply that the value of having a physiotherapist in an 
exercise class or part of individual treatment has a significant effect on 
depression (See section 4.2.2). The hypothesis could therefore be that 
professional guidance and support is a valuable adjunct to treatment. 
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In the Exercise Class Group there was a 49% improvement from baseline at six 
weeks, 56% improvement from baseline at six months but at one year there 
was deterioration in the score back to the level recorded at six weeks (48%). In 
the Multimodal Group there was a 37% improvement from baseline at six 
weeks, 43% improvement at six months and 59% at one year. In the Home 
Exercise Group there was a 23% improvement from baseline at six weeks, 24% 
improvement from baseline at six months and 30% improvement at one year.  
 
In contrast, HADS-D yielded three different patterns of scores across the three 
groups with only the Home Exercise Group showing a small consistent 
improvement. This proposes a question that is difficult to answer due to the fact 
that no other similar studies have reported on this outcome measure with this 
population of patients. The physiotherapy intervention provided does not have a 
direct active component that addresses depression. This may be why this 
inconsistency is evident. It may suggest that physiotherapists should consider 
addressing depression prior to treatment and adopt more strategies to impact 
positively on these scores and consequently lead to greater patient satisfaction. 
This would support the use of a biopsychological outcome measure in the 
assessment of patients with a diagnosis of frozen shoulder. Alternatively, the 
Constant score, OSS and HADS-A have been consistent with the findings of 
this study and have confirmed that they are important for clinical practice, 
however these results reveal that the HADS-D score is not appropriate for use 
in the physiotherapy practice of patients referred with frozen shoulder. 
Therefore, further research needs to be conducted to identify a suitable tool to 
measure depression in patients with frozen shoulder. 
 
4.5.2.3 SF-36  
The only significant difference with the effect of time was found in the 
dimensions of Social Functioning and Bodily Pain. They showed a significant 
improvement between six weeks and one year and between six months and 
one year. The reasons for this have previously been discussed in section 4.2.3 
which highlights the issue of whether the SF-36 is an appropriate outcome 
measure for the use with a diagnosis of frozen shoulder. 
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4.6 AGREEMENT BETWEEN THE SCORES 
 
The Constant score (p=0004), Oxford Shoulder Score (p<0.001) and HADS-A 
(p<0.001) are all in agreement between the different main effects, except from 
HADS-D (p=0.359) which did not show a significant change between the 
groups.  
 
The scores show that the patients in the Exercise Class Group are significantly 
better than those in the Multimodal Group and in the Home Exercise Group. 
The results also show that the patients in the Multimodal Group demonstrate 
greater improvement than the Home Exercise Group. This supports the 
hypothesis that the intervention of a physiotherapist in the Exercise Class 
Group or in the Multimodal Group was superior to the Home Exercise Group. 
 
This is in contrast to the work by Levine et al (2007) who suggest that patients 
placed on a therapist directed home exercise programme had the same 
outcomes at short and long term follow-ups as those treated with other 
interventions. Kivimaki et al (2007) compared patients treated with a home 
exercise programme to those with manipulation under anaesthetic and a home 
exercise programme. Other than a slight increase in ROM, the group performing 
just a home exercise programme did not differ at any follow up in pain or 
working ability.  
 
In this current study, exercise within pain limits, as used in the home exercises, 
was given to all three groups and has previously been shown to be more 
effective than intensive physiotherapy in frozen shoulder patients (Diercks and 
Stevens 2004). They presented a series of patients treated with supervised 
neglect and a control group that received formal physical therapy. Supervised 
neglect included pendulum and active exercises in the pain-free range and 
instructions to resume all tolerable activities. After two years from the start of 
treatment, 89% of patients treated with supervised neglect had normal or near 
normal shoulder function compared to 63% of patients treated successfully with 
intensive physiotherapy. However, it is important to note that both treatments 
were more than 50% effective and that there was no long term evidence of 
efficacy of either method.  
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4.7 DISCUSSION OF PATIENT CHARACTERISTICS 
 
The baseline characteristics of the study‟s population were surprisingly good 
when compared to the generally accepted aetiology of the condition. Excellent 
comparity was not expected due to the sample size and time available for this 
study. However, the results were comparable with the findings of Reeves (1975) 
and Binder et al (1986) who suggest that frozen shoulder is most common 
between the ages of 40-70. The results also agree with the findings by Bunker 
(2009) that the evidence suggesting a ratio of female to male was 1:1.  
Although, this is in contrast to the findings of Binder et al (1984), who suggest 
that approximately 70% of patients presenting with frozen shoulder are women.  
 
Kelly et al (2009) have stated that “there is no clear evidence to determine 
which patients may need formal supervised therapy than simply a home 
exercise programme” (Kelly, 2009:197). However, the findings of this study 
support the use of an exercise class in the treatment of the patients with these 
characteristics and a true diagnosis of frozen shoulder and provide substantial 
evidence to confirm this.  
 
4.8 METHODOLOGICAL ISSUES 
 
The author encountered difficulties with slow patient recruitment. This has 
previously been reported in other studies in recruiting patients with frozen 
shoulder, resulting in trial termination (Carette et al 2003). The study was 
extended for another year to prevent a relatively small sample size. This was 
confirmed by Bunker and Anthony (1995) who suggest that frozen shoulder is 
relatively rare, accounting for only 50 out of 935 shoulder referrals. Patients 
were recruited from new referrals to the physiotherapy clinics within Ashton 
Wigan and Leigh Primary Care Trust and Wrightington, Wigan and Leigh NHS 
Foundation Trust, with a diagnosis of frozen shoulder. 110 patients out of 850 
patients assessed for eligibility had shoulder pain attributable to causes other 
than frozen shoulder, suggesting that general practitioners are poor at 
recognising this clinical entity. Even more interesting however, was that of these 
patients seen by the physiotherapists and diagnosed with frozen shoulder, 20 
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actually had signs more consistent with impingement. This highlighted a need 
for further training in the physiotherapy service across the trust and how difficult 
it was to diagnose a „true‟ frozen shoulder.  
 
Reeves (1975) documented three phases with which to address the progression 
of frozen shoulder: the pain phase, the stiffness phase and the recovery phase. 
The patients were in the second phase with a mean duration of six months. The 
results of this study therefore cannot be generalized to other patients at various 
stages of signs or symptoms.  
 
All outcome measures were presented within a booklet. The booklet was printed 
and not photocopied so that all VAS lines were exactly 10 centimetres long. The 
outcome measures were completed in the same order to ensure consistency in 
the methods. The trial physiotherapist also made sure that all questions had 
been answered at each assessment thus enhancing quality of data and 
minimising non-completion. The trial physiotherapist also had an established 
rapport with all patients and was available to answer any questions or concerns. 
Every care was taken to ensure that nothing was said that could sway patients‟ 
responses and that all of the outcome measures were explained in the same 
manner to each patient, ensuring that they felt it was a true account of how they 
felt at that particular assessment point.  
 
The study also benefited from the effort to minimise inter-operator 
inconsistencies with the use of a trial physiotherapist who taught the home 
exercises to all groups and recorded the outcome measures. The trial 
physiotherapist made all the calculations, anonymised all data and inputted all 
data to a password-protected database. This was completed weekly and 
diligently, ensuring enhanced consistency of data with less error.  
 
Another important issue to consider is the potential of both patient and 
researcher bias due to lack of blinding in this study. It would be impossible to 
blind the patients to their treatment with the inclusion of exercise as an 
intervention. However, this is similar in most studies which investigate the 
efficacy of physiotherapy intervention (Koes and Hoving 1998). 
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Potential bias was reduced by not allowing the patient or the trial 
physiotherapist access to prior results until raw data was analysed at 
completion of the study. It was also minimised by the strict standardised 
procedure of measurement of the objective primary outcome measure, the 
Constant score. The use of a secondary subjective measure, the Oxford 
Shoulder Score, as previously discussed, limited potential observer bias due to 
the use of patient recording. 
 
To control the threats of internal validity, the interventions have to be very 
specific and well defined. By reducing the number of variables one will know 
exactly which element of treatment had the specific resultant effect. However, in 
physiotherapy one rarely gives a specific treatment in isolation. One would 
diagnose and formulate an individual patient specific treatment plan, which 
incorporated a variety of treatment techniques to address all the component 
problems of their frozen shoulder. Subsequently, once effects of specific 
interventions in isolation have been found one needs to consider interventions 
in combination. An intervention, which may not have been found to be beneficial 
in isolation, may markedly improve outcome when combined with another 
intervention. An important point to consider is that by maintaining rigorous 
experimental control the external validity of the randomised controlled trial is 
compromised. One can only conclude the effects of a very specific intervention 
on a very specific population, which may reflect neither the typical presenting 
population nor the varied treatment received in clinical practice. Only by 
developing research into the combination of treatment components can one 
hope to determine the best evidence based practice. This apparent need for 
scientific studies evaluating combined treatments was highlighted by Green et 
al (2003; 2009) who appreciated that this is the norm rather than the exception 
in practice. Foster et al (2009) agree that typically therapies are delivered as 
part of a package of care, rather than as a single intervention which does 
indeed complicate the design of trials to test treatment effectiveness. They do 
therefore, recommend that one should define the various components of the 
intervention and determine the characteristics of patients that may respond to a 
multi-modal intervention. 
 
4.9 IMPLICATIONS FOR CLINICAL PRACTICE 
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This study has confirmed that patients seen in an exercise class and supervised 
by a physiotherapist had better outcomes and recovered in a shorter time frame 
than those patients on a home exercise programme. This can influence clinical 
practice. It may potentially reduce the number of individual physiotherapy 
treatment sessions which would impact upon both waiting times and budgets. 
Patients were taught self management of their condition and how to deal with 
any increase in pain. The trial physiotherapist hypothesised that behavioural 
changes during the treatment period, relating to improvement of self – 
management due to the exercise class, would reduce the utilization of health 
care services during the follow up period and reduce sick leave in patients.  
 
The need for only one physiotherapist to treat a group of patients would 
increase cost effectiveness and improve care pathways by initiating effective 
management from initial diagnosis. It would standardise treatment outcomes 
and impact upon the need for surgical implications.  
 
Clinicians need to be made aware of the psychological issues when treating a 
patient with frozen shoulder. They should be encouraged to assess changes or 
problems that occur in a patient‟s wider context during routine assessment. 
Such issues as sick leave as a response to disease activity need to be 
considered. Awareness of these changes could guide interpretation of disease 
status leading to informed clinical decision-making and instigation of appropriate 
interventions. The reason for a poor response to treatment or increase in 
psychological distress could be related to their ability to cope with their 
condition. The inclusion of a psychosocial screening tool as part of routine care 
would enable clinicians to see patterns developing in changes with 
psychological status. The use of HADS in clinical practice as a screening tool 
for patients with a diagnosis of frozen shoulder could be beneficial in that it can 
highlight patients who would benefit more from face to face physiotherapy 
interventions rather than exercising at home. The use of outcome measures 
should be used to highlight patients who are less likely to respond to this 
treatment type allowing the most effective course of treatment prescribed. 
Based on the findings of this study, the assessment and identification of 
patients with high levels of anxiety and depression should be given high priority, 
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particularly given their influence on aspects such as quality of life, pain 
experiences and treatment conformity. 
 
The study highlights a need to educate primary care physicians and those 
health professionals involved in the diagnosis and management of frozen 
shoulder. Once identified, referral should be made into secondary care for 
prompt assessment, rehabilitation, education and instigation of a supervised 
exercise class. Such treatment pathways would ensure that patients received 
appropriate treatment and effective management of frozen shoulder and thus 
reduced the impact of the condition. 
 
4.10 FURTHER WORK 
 
There are several avenues to pursue in future investigations. The usefulness of 
a home exercise programme was not in question but compliance to a home 
exercise programme could be an issue with some patients (O‟Doherty et al 
2007). Wilcox et al (2006) performed a study investigating perceived barriers to 
exercise in patients with musculoskeletal pain. They identified many factors that 
affect adherence to a home exercise programme such as pain, psychological 
barriers such as attitudes and beliefs, lack of time, motivation and enjoyment of 
exercise. Further study relating to the compliance of a home exercise regime 
would enhance the physiotherapy programme in the treatment of frozen 
shoulder. It would also be valuable to investigate the potential long term benefit 
of physiotherapy in the management of frozen shoulder. Other research could 
focus on the effect of physiotherapy following surgical intervention in patients 
with a diagnosis of frozen shoulder e.g. MUA or arthroscopic release. 
 
 
 
 
 
5.0 CONCLUSION 
  
The efficacy of the treatments of frozen shoulder has rarely been evaluated in 
randomised controlled trials. It is difficult to draw reliable conclusions about the 
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efficacy of one treatment versus the other on the current studies. This ambiguity 
stems from factors that include the design of the studies, the general lack of a 
control group, the timing of the intervention and the variable natural history of 
the disorder. The debate on the effectiveness of physiotherapy in the treatment 
of frozen shoulder continues. The length of physiotherapy intervention and the 
stage at which it may be appropriate, has not been justified thus far in the 
research. Based on the limited quality of high grade evidence, it has been 
concluded that for many patients with frozen shoulder, home exercises will 
result in major improvements, sparing many patients from more aggressive and 
higher risk treatments. This study has completed the objectives of developing, 
implementing and evaluating the efficacy of the most appropriate management 
of frozen shoulder. The research study considered three interventions 
commonly used by physiotherapists in the treatment of frozen shoulder. The 
results suggest that an exercise class is superior in relieving the signs and 
symptoms of frozen shoulder.  
 
Therefore, it seems reasonable to use a hospital based exercise class aimed at 
a rapid recovery rate with a minimum number of visits to the hospital after which 
a follow up period with a home based exercise programme would be 
recommended. 
 
5.1 KEY RECOMMENDATIONS  
 
 Frozen shoulder should be managed in an exercise class. If this is not 
possible then physiotherapy is a good alternative to optimise the speed 
of recovery of frozen shoulder. 
 The Constant score, OSS and HADS are useful outcome measures in 
the management of frozen shoulder. The SF-36 is not a useful outcome 
measure to assess general health for patients with frozen shoulder.  
 Training for GPs and physiotherapists in the clinical diagnostic accuracy 
of frozen shoulder. 
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APPENDIX ONE 
 
 
 
 
 
Inclusion sheet 
 
INCLUSION TO FROZEN SHOULDER STUDY 
 
 
Patient’s Name   .......................................................   Date   ............................... 
 
Insidious onset    Yes              No          
 
Intervention in last six weeks  Yes              No          
 
State .................................................……………………………………………….. 
 
Duration of symptoms (established   .................................................................... 
 
Dominant side    Left              Right       
 
Affected shoulder    Left              Right       
 
X-ray clear of gleno-humeral joint OA Yes              No          
 
X-ray findings 
 
 
Past Medical History Significant joint problems 
 
............................................................................................................................... 
 
............................................................................................................................... 
 
Drug History …………………………………………………………………… 
 
Steroid injections  Yes            No        Where?  …………..…….. 
 
How many?   ......................................   When?   .............................................. 
Diabetic      Yes     No     Type   ................................................... 
 
Smoker      Yes     No        Less than 10     10 or more        
 
Litigation pending    Yes              No          
 
Social History Occupation    …………………………………………………... 
 
Able to work at normal capacity   Yes            No        
 
Occupational type - 
 Heavy manual    Moderate manual   
 Light manual     Sedentary    
 
RANGE OF MOVEMENT OF AFFECTED SHOULDER 
 Affected Shoulder Unaffected Shoulder 
Abduction 
Active a1 b1 
Passive a1 b1 
Lateral 
Rotation 
Active a2 b2 
Passive a2 b2 
 
 
  
 
 
 
 
 
APPENDIX TWO 
 
 
 
 
 
Patient information sheet 
 
 
 
Hand Unit Research Department 
Wrightington Hospital 
Hall Lane 
Appley Bridge 
Wigan 
Lancs 
WN6 9EP 
 
01257 256248 
 
 
PATIENT INFORMATION SHEET 
 
 
What is the most effective conservative management of the frozen 
shoulder? 
 
Name of Researcher:  Mrs S Russell 
 
 
You are being invited to take part in a research study.  Before you decide it is 
important for you to understand why the research is being done and what it will 
involve.  Please take time to read the following information carefully and discuss 
it with others if you wish.  Ask us if there is anything that is not clear or if you 
would like more information. Take time to decide whether or not you wish to 
take part. 
 
Thank you for reading this. 
 
What is the purpose of this study? 
 
You have the condition of frozen shoulder.  It is a condition that usually gets 
better eventually but this can take two to three years.  Many different 
physiotherapy treatments have been tried such as supervised exercise; advise 
on home exercises and individual treatment from a physiotherapist.  It is not 
known which people will benefit most from these different treatments and this 
study is designed to compare the results of these different treatments. 
 
What happens to me if I take part? 
 
If you agree to enter this study the treatment you receive will be the same type 
of treatment as if you were not in the study.  We will record information about 
your problem and check how much you can move it and how strong it is.  We 
will repeat these tests and ask you to complete a questionnaire on occasions 
when you attend in the future.  You will receive either type of physiotherapy.  
Our assessment of your shoulder indicates that you would be suitable for either 
treatment.  Which treatment you receive will be decided by a method called 
 
randomisation.  This means that the decision cannot be influenced by you or 
any of the research workers.  This will decide which treatment you will receive 
and you must be happy to have either form of physiotherapy. 
 
What do I have to do? 
 
The main part of this study will last about six months.  During this time you can 
take any usual medication you have along with your pain killers or anti 
inflammatory medication you need to help the pain.  You will be asked to fill in a 
set of questions about your condition at the beginning of the study and then 
every month when you attend for a treatment session.  We would also like you 
to attend once more in two years time to fill in the questions again.  
Reimbursement of travelling expenses will be available for this “extra visit” 
   
 
What does the Exercise Class Involve? 
 
You will be given advice about the condition and appropriate medication.  You 
will then attend the physiotherapy department to be instructed on exercises in a 
class setting twice per week.  Advice sheets will be also be issued to assist this.  
You will be seen and reassessed at intervals.  If after 3 months you have not 
improved you will be given the opportunity to see a surgeon to discuss further 
treatment. 
 
What does Individual Treatment Involve? 
 
You will be given advice about the condition and appropriate medication.  You 
will then attend the physiotherapy department and receive treatment by a senior 
physiotherapist twice per week.  You will also be instructed on how to exercise 
at home.  Advice sheets will also be issued to assist this.  You will be seen and 
reassessed at intervals.  If after 3 months you have not improved you will be 
given the opportunity to see a surgeon to discuss further treatment. 
 
What does the Home Exercise Programme Involve? 
 
You will be given advice about the condition and appropriate medication.  You 
will then attend the physiotherapy department to be instructed on how to 
exercise at home.  Advice sheets will also be issued to assist this.  You will be 
seen and reassessed at intervals.  If after 3 months you have not improved you 
will be given the opportunity to see a surgeon to discuss further treatment. 
 
What are the possible advantages of taking part? 
 
There are no risks to being part of this study because we are only offering 
treatments that are in regular use at the present time.  Some pain or discomfort 
would normally be experienced with the treatments anyway and you will be 
given appropriate advice about medication.  The main disadvantage is the need 
to fill in questionnaires but these are not complicated and will mainly be given to 
you during a routine attendance. 
 
All people who have been referred to Wrightington, Wigan and Leigh NHS Trust 
who have frozen shoulder and could be treated by either type of physiotherapy 
are being considered for this study. 
 
Do I have to take part? 
 
It is entirely up to you to decide whether or not to take part.  If you do decide to 
take part you will be given this information sheet to keep and be asked to sign 
the appropriate consent form.  If you decide to take part you are still free to 
withdraw at any time and without giving a reason.  You can be assured that this 
will not affect any future care you will receive at this hospital. 
 
What are the benefits of taking part? 
 
It may well be that you will not benefit personally from this research, but 
obviously it will have significant impact on how frozen shoulder is treated in the 
future. 
 
Whilst there is no payment for your inclusion in this research, you can be 
assured that the normal compensation arrangements that are applicable to all 
patients undergoing treatment will apply in your case. 
 
Will my taking part in this study be kept confidential? 
 
All information, which is collected about you during the course of this research 
will be kept and treated in a strictly confidential manner.  Any information about 
you, which leaves the hospital, will have your name and address removed so 
that you cannot be recognised from it.  If a scientific paper is written about the 
results your name and address will be removed completely. 
 
Who has reviewed this study? 
 
The Wrightington Wigan and Leigh local research and ethics committee have 
reviewed this study. 
 
Contact for further information 
 
Sarah Russell:- 01942 822100 
 
Thank you for agreeing to take part in this study 
   
  
 
 
 
 
 
APPENDIX THREE 
 
 
 
 
 
Patient consent form 
           Hand Unit Research Department 
           Wrightington Hospital 
           Hall Lane 
            Appley Bridge 
           Wigan 
           Lancs 
           WN6 9EP 
           Tel: 01257 256248 
 
 
PATIENT CONSENT FORM 
 
Title of Project: What is the most appropriate management of a frozen Shoulder? 
Name of Researcher: Mrs Sarah Russell (ESP) 
Patient Identification Number:  
Version 1.  May 2005 
                      Please initial box 
 
I confirm that I have read and understood the information sheet  
dated  …………………..   
For the above study and have had the opportunity to ask questions.  
 
I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving reason, without my medical 
care or legal rights being affected.  
 
I understand that sections of any of my medical notes may be looked 
at by responsible individuals from Wrightington hospital or from 
Regulatory authorities where it is relevant to my taking part in the 
research.  I give my permission for these individuals to have access 
to my records.  
 
I agree to my GP being informed that I am taking part in this study. 
 
I agree to take part in the above study.  
 
 
_________________________     ________________ ______________________ 
Name of Patient       Date        Signature 
 
 
 
_________________________     ________________ ______________________ 
Name of Person taking consent     Date   Signature 
(if different from Researcher)        
 
 
_________________________     ________________ ______________________ 
Researcher        Date   Signature 
 
(Copy to patient, copy to researcher and copy kept with Hospital Notes
 
 
 
 
  
 
 
 
 
 
APPENDIX FOUR 
 
 
 
 
 
Outcome measures 
- Constant Score 
- Oxford Shoulder Score 
- SF-36 Short Form 36 
item health survey 
- HADS 
A. Pain     A 
 
1. Do you have pain in your shoulder (normal activities)? 
 
No               Mild pain               Moderate               Severe or permanent   
  
 
2. Linear Scale: 
 
If ‘0’ means no pain and ‘10’ is the maximum pain you can experience, please circle 
where is the level of pain of your shoulder.   
 
Level of Pain   
 
          At Rest                    0                                                                                                                        10 
 
  
With Use  0                                                                                                 10 
 
  
At Night  0                                                                                                                        10 
 
B. Activities Of Daily Living    B 
 
1. Is your occupation or daily living limited by your shoulder? 
  
 No                Moderate limitation                 Severe limitation      
  
 
2. Are your leisure and recreational activities limited by your shoulder? 
 
 No                Moderate limitation                 Severe limitation      
 
3. Is your night sleep disturbed by your shoulder? 
 
 No      Sometimes          Yes      
 
4. State to what level you can use your arm for painless, reasonable activities. 
 
 Waist          Lower Chest           Neck          Head          Above Head     
 
C. Range Of Movement   leave this for the doctor or physiotherapist   C 
 
1. Forward Flexion                               2. Abduction  
 
 
3. External Rotation       4. Internal Rotation (dorsum hand to) 
 
 Hand behind head and elbow forward   2 Thigh    0 
 Hand behind head and elbow back   4 Buttock    2 
 Hand above head and elbow forward   6 SI joint    4 
 Hand above head and elbow back   8 Waist    6 
 Full elevation of arm               10 T12    8 
       Between shoulder blades          10 
 
D. Power kg x 2  D 
CONSTANT SCORE Inclusion 
Following Intervention 
6 Months 
Year 
Patient ID 
OXFORD SHOULDER SCORE     
 
Problems with your shoulder DURING THE PAST 4 WEEKS …. 
 
 Tick one box for each question                      Right       Left      
 
 
 1 
Could you carry a tray containing a plate of food across a room? 
 
   Yes, easily       With little difficulty    With moderate difficulty    With extreme difficulty    No, impossible 
 
Have you had any trouble dressing yourself because of your shoulder? 
 
No trouble at all       A little bit of trouble      Moderate trouble       Extreme difficult        Impossible to do 
 
Have you had any trouble getting in and out of a car or using public transport because of your shoulder? 
 
No trouble at all     A little bit of trouble        Moderate trouble     Extreme difficulty         Impossible to do 
 
Have you been able to use a knife and fork  -  at the same time? 
 
   Yes, easily           With little difficulty With moderate difficulty   With extreme difficulty   No, impossible 
 
Could you do the household shopping on your own? 
 
   Yes, easily         With little difficulty   With moderate difficulty   With extreme difficulty    No, impossible 
 
Could you hang your clothes up in a wardrobe,  -  using the affected arm? 
 
   Yes, easily       With little difficulty    With moderate difficulty     With great difficulty   No, impossible 
 
Could you brush/comb your hair with the affected arm? 
 
   Yes, easily     With little difficulty    With moderate difficulty     With extreme difficulty       No, impossible 
 
How would you describe the pain usually had from your shoulder? 
 
         None                       Very Mild                      Mild                     Moderate                        Severe 
 
How would you describe the worse pain you had from your shoulder? 
 
         None                           Mild                      Moderate                    Severe                     Unbearable 
 
Have you been able to wash and dry yourself under both arms? 
 
     Yes, easily   With little difficulty  With moderate difficulty   With extreme difficulty   No, impossible 
 
How much has pain from your shoulder interfered with your usual work (including housework)? 
 
      Not at all                  A little bit                 Moderately                   Greatly               Totally 
 
Have you been troubled by pain from your shoulder in bed at night? 
 
   No night             Only 1 or 2 night             Some nights              Most night                   Every night 
 
2 
11 
10 
9 
8 
7 
3 
6 
5 
4 
12 
Inclusion 
Following Intervention 
6 Months 
Year 
Patient ID 
YOUR HEALTH AND WELL-BEING 
 
The following questions ask for your views about your health and 
how you feel about life in general.  If you are unsure about how to 
answer any question, try and think about your overall health and give the best answer 
you can.  Do not spend too much time answering as your immediate response is likely to 
be the most accurate.  For each of the following questions please put a cross in the box that 
best describes your answer. 
 
1.   In general, would you say your health is: 
 
      Excellent   Very good   Good       
      Fair   Poor   
-------------------------------------------------------------------------------------------------------------------- 
 
2.   Compared to 3 months ago, how would you rate your health in general now? 
 
      Much better than 3 months ago     Somewhat better than 3 months ago     
      About the same        Somewhat worse now than 3 months ago      
      Much worse now than 3 months ago  
-------------------------------------------------------------------------------------------------------------------- 
 
3.  The following questions are about activities you might do during a typical 
day.  Does your health limit you in these activities?  If so, how much? 
 
                         Yes,                  Yes,         No, not 
                       limited              limited             limited 
                                                                    a lot                  a little              at all 
a.   Vigorous activities, such as running, lifting                                          
      heavy objects, participating in strenuous sports 
b.   Moderate activities, such as moving a table,                              
      pushing a vacuum, bowling or playing golf 
c.   Lifting or carrying groceries                                          
d.   Climbing several flights of stairs                              
e.   Climbing one flight of stairs                               
f.    Bending, kneeling or stooping                                         
g.   Walking more than a mile                               
h.   Walking half a mile                                
i.    Walking 100 yards                                
j.    Bathing and dressing yourself                              
------------------------------------------------------------------------------------------------------------------ 
 
4.  During the past 2 weeks, how much time have you had any of the following problems 
with your work or other regular daily activities as a result of your physical health? 
 
                        All of       Most       Some      A little      None 
                                                                                                the        of the       of the       of the      of the 
                                                                                                time         time         time         time        time 
a.   Cut down on the amount of time you                                   
 spent on work or other activities 
b.   Accomplished less than you would like                                   
c.   Were limited in the kind of work or other                                   
 activities 
d.   Had difficulty performing the work or                                    
 other activities (eg it took more effort) 
Patient ID 
Inclusion 
Following Intervention 
6 Months 
Year 
 
5.    During the past 2 weeks, how much time have you had any of the following       
problems with your work or other regular daily activities as a result of any 
emotional problems (such as feeling depressed or anxious)? 
 
                                                                                                All of       Most       Some      A little      None 
                                                                                                 the        of the       of the       of the      of the 
                                                                                                 time         time         time         time         time 
a.     Cut down on the amount of time you                                    
   spent on work or other activities 
b.     Accomplished less than you would like                                     
c.     Didn’t do work or other activities as                                     
   carefully as usual 
-------------------------------------------------------------------------------------------------------------------- 
 
6.  During the past 2 weeks, to what extent have your physical health or 
emotional problems interfered with your normal social activities with family, 
neighbours or groups?  
  Not at all    Slightly   
  Moderately         Quite a bit   
  Extremely   
------------------------------------------------------------------------------------------------------------------- 
 
7.     How much bodily pain have you had during the past 2 weeks? 
  None   Very mild  Mild            
  Moderate  Severe   Very severe      
-------------------------------------------------------------------------------------------------------------------- 
 
8.     During the past 2 weeks, how much did pain interfere with your normal work 
(including both outside the home and housework)? 
  Not at all    Slightly   
  Moderately         Quite a bit   
  Extremely   
-------------------------------------------------------------------------------------------------------------------- 
 
9.     These questions are about how you feel and how things have been with you 
during the past 2 weeks.  For each question please give one answer that 
comes closest to the way you have been feeling. 
 
                                                                              All of        Most     A good       Some         A little        None 
                                                                                               the         of the      bit of          of the         of the        of the 
                                                                                              time         time      the time        time           time           time 
a.     Did you feel full of Life?                                                         
b.     Have you been a very nervous person?                                   
 
c.     Have you felt so down in the dumps                                        
        that nothing would cheer you up? 
d.     Have you felt calm and peaceful?                                         
e.     Did you have a lot of energy?                                         
f.      Have you felt downhearted and low?                                      
g.     Did you feel worn out?                                          
h.     Have you been a happy person?                                         
i.      Did you feel tired?                                            
10.    During the past 2 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting 
friends, relatives, etc.)? 
 
   All of the time      
Most of the time   
   Some of the time     
A little of the time   
   None of the time   
-------------------------------------------------------------------------------------------------------------------- 
 
11.   How TRUE or FALSE is each of the following statements for you? 
 
        Definitely       Mostly          Not          Mostly      Definitely 
                                                                                True            True           Sure          False          False 
 
a.     I seem to get ill more easily                                                                       
        than other people 
 
b.     I am as healthy as anybody I                                                                                
         know   
 
c.     I expect my health to get worse                                                                       
d.     My health is excellent                                                                        
------------------------------------------------------------------------------------------------------------------- 
 
 
 
The Hospital Anxiety and Depression Scale
Name Date
Clinicians are aware that emotions play an important part in most illnesses. lf your
clinician knows about these feelings, he or she will be able to help you more. This
questionnaire is designed to help your clinician know how you feel. Read each item
and place a flrm flck ln the box opposlte the reply whlch comes closest to how you
have been feeling in the past week.
Don't take too long over your replies; your immediate reaction to each item will
probably be more accurate than a long thought-out response. Tick only one box in
each section. Please answer everv question.
(A) lfeel tense orwound up:3 Most of the time2 a lot of the time
1 Time to time, occasionally0 Not at all
(D) I still enjoy the things I used to enioy:0 Definitely as much1 Not quite as much2 Only a little3 Hardly at all
(A) I get a sort of frightened feeling as if something
awful it about to happen:3 Very definitely and quite badly
2 Yes, but not too badly1 A little, but it doesn't worry me0 Not at all
(D) I can laugh and see the funny side of things:0 As much as I always could1 Not quite so much now
2 Definitely not so much now3 Not at all
(A) Worrying thoughts go through my mind:3 A great deal of the time
2 A lot of the time1 From time to time, but not too often0 Only occasionally
(D) lfeel cheerful:3 Not at all2 Notoften
1 Sometimes0 Most of the time
(A) I can sit at ease and feel relaxed:0 Definitely1 Usually
2 Notoften3 Not at all
(D)
3
2
1
0
I feel as if I am slowed down:
Nearly allthe time
Very often
Sometimes
Not at all
(A) I get a sort of frightened feeling like
"butterflies" in the stomach0 Not at all
1 Occasionally
2
3
ffi
(D)
3
2
1
0
(A)
3
2
1
0
(D)
0
1
2
3
(A)
3
2
1
0
Quite often
Very often
I have lost interest in my appearance:
Definitely
don't take as much care as I should
may not take quite as much care
take just as much care as ever
I feel restless as if I have to be on the move:
Very much indeed
Quite a lot
Not very much
Not at all
I look forward with enioyment to things:
As much as I ever did
Rather less than I used to
Definitely less than I used to
Hardly at all
I get sudden feelings of panic:
Very often indeed
Quite often
Not very much
Not at all
(D) I can enjoy a good book or radio or TV
programme:
0 Often1 Sometimes
Not often
Very seldom
!tb!ji:+t#i:r!fr*i#
gl,*rF:ii*1-iil+:€
ri:'!:'ll
ilraii:i-ilJii1i,,:.1g
2
3
ffi
srAFF scoRlNG Totals: Dep = 121; Anx = 121
lnterpreting scores:
Clinical cut-offs in non-chronic pain population
(score out of 2l for each dimension):
0-8 = Normal Range8-10 = Borderline clinical anxious/depressed (ie Mild)
11-14 = Moderate15+ = Severe
Zigmond and Snaith, 1983. Acta Scandinavica, 67, p361-70
  
 
 
 
 
 
 
APPENDIX FIVE 
 
 
 
 
 
GP letter 
 
 
 
 
 
       
  
  
                                                            Hand Unit Research Department 
RE:                                                         Wrightington Hospital 
      Hall Lane 
      Appley Bridge 
      Wigan 
      Lancs 
      WN6 9EP 
               Tel: 01257 256248  
  
  
GP INFORMATION SHEET 
 
        Comparison of Conservative Management of the Frozen Shoulder? 
 
  
Your patient has agreed to enter a trial that is being performed within 
Wrightington, Wigan and Leigh NHS Trust to compare different types of 
physiotherapy treatment for a Frozen Shoulder.   
  
There will be three groups receiving either of the treatments after 
randomisation.  They are eligible because they are suitable for either method of 
treatment.  After 3 months the physiotherapy group will be offered surgery if 
they wish it.  All participants will fill in functional scoring questionnaires at 
intervals for about 6 months and again at 2 years to assess the progress they 
are making. 
  
Whilst they are in the study there will be no restriction on what analgesic or anti-
inflammatory medication they receive.  We would ask that they are not 
prescribed steroids or given steroid injections to the shoulder whilst they are in 
the study. If you think such treatment is indicated, please contact us and we will 
arrange a follow up visit as soon as possible.  Should they require oral steroids 
for some other condition then clearly they should be given.  This study should 
not influence how you treat your patient for other conditions they may have.  If 
you have any concerns about the treatment of their frozen shoulder please 
contact me on 01257256289 or Robert Conlon, Physiotherapist on 
01257256533 
  
I enclose a copy of the patient information sheet for your information. 
  
  
  
Mrs Sarah Russell  
Extended Scope Practitioner  
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Patient information booklet 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                          
  
 
 
 
 
In conjunction with 
Wrightington, Wigan & Leigh NHS Trust 
 
 
 
 
 
 
PHYSIOTHERAPY SERVICE 
 
 
 
 
 
FROZEN SHOULDER/ 
ADHESIVE CAPSULITIS 
 
 
 
 
 
 
 
Patient Information Leaflet 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ashton, Leigh & Wigan 
Primary Care Trust 
 
 
 
 
PATIENT ADVICE AND LIAISON SERVICE (PALS) 
 
The PALS are able to provide ‘on the spot’ help and advice to 
patients, carers, friends and families.  We will listen to you and 
provide you with relevant information and support, to help 
resolve any concerns or problems you may have that you do not 
wish to discuss with a member of staff, as quickly and efficiently 
and confidentially as possible. 
 
If you have a concern, or need help or information, you can 
contact the PALS and we will do our best to help you.  We can 
be contacted Monday to Friday, 9.00 am to 5.30 pm on 01942 
822376 – outside these hours there is an answer phone service 
available. 
 
Alternatively, we can be contacted by bleep.  Just ring the 
switchboard on the main Leigh Hospital number (01942 672333) 
and ask them to bleep us on 2376. 
 
If they are unable to allay your concerns and you feel you would 
like to take your complaint further, you can write to: 
 
 
The Complaints Manager 
Ashton, Leigh & Wigan PCT 
Bryan House 
Standishgate 
Wigan 
WN1  1AH 
 
 
 
 
 
 
 
 
 
 
 
 
 
Author:   Sarah Russell 
Review Date:   May 2008 
 
WHAT IS FROZEN SHOULDER/ADHESIVE 
CAPSULITIS? 
 
Frozen shoulder is an extremely painful condition in which the 
shoulder is completely or partially unmovable.  Frozen 
shoulder often starts without any serious cause but may be 
triggered by a mild injury to the shoulder.  The condition goes 
through three phases, starting with pain, then stiffness and 
finally a stage of resolution as the pain eases and most of the 
movement returns.  This process may take an awfully long 
time, sometimes as long as two or more years. 
 
 
 
Three Stages of Development 
 
 
 
Typically frozen shoulder develops slowly, and in three stages:  
 
 
 Stage One:  Pain increases with movement and is often 
worse at night.  There is a progressive loss of motion with 
increasing pain.  This stage lasts approximately 2 to 9 
months. 
 
 
 Stage Two:  Pain begins to diminish; however the range 
of motion is now much more limited, as much as 50% less 
than in the other arm.  This stage may last 4 to 12 months. 
 
 
 Stage Three:  The condition may begin to resolve.  Most 
patients experience a gradual restoration of motion over 
the next 12 to 42 months. 
 
 
 
TREATMENT 
 
Many different treatments have been tried varying from surgery to 
physiotherapy or advice alone.  At present it is not known which of 
these is the most effective. 
 
SELF HELP 
 
Analgesia or Painkillers 
 
Heat 
 
Resting Positions 
 
Sleep can be uncomfortable if you try and lie on your affected arm.  
We would recommend that at first you lie on your back or on the 
opposite side.  If you lie on your back, support your affected arm.  
Make sure that your elbow is above your shoulder.  If you are on 
your side then a folded pillow supports your affected arm from your 
elbow to your wrist. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Posture 
 
Poor posture can aggravate your symptoms.  It is advisable 
to: 
 
 
 Always try and maintain an upright position.  This 
applies to standing, walking or sitting. 
 
 Maintain the lumbar lordosis in all positions. 
 
 Change position frequently. 
 
 Avoid slouching. 
 
 
 
 
 
 
 
 
 
 
 
Sitting 
 
 When sitting, maintain the lumbar lordosis. 
 
 Use a rolled up towel and place in the bottom of your 
back. 
 
 Use a chair with some lumbar support, if possible. 
 
 Use a straight back, firm chair. 
 
 Use a chair that is not too low. 
 
 When  sitting  on  an  easy chair  or  settee,  use 
your lumbar roll and change position. 
 
 DO NOT SLOUCH 
 
 Avoid crossing legs or curling legs underneath. 
 
 Sit straight in a chair, not leaning to one side. 
 
 Do  not  sit  for prolonged  periods;  get  up  and 
move around. 
 
 Take care when getting in and out of a chair. 
Stand in front of the chair, bend the knees at the same 
time and place the hands behind you to rest on the seat or 
arms of the chair. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TENS MACHINES 
 
Transcutaneous electrical nerve stimulator (TENS) is effective 
for many people in the reduction of pain. 
 
By passing electrical pulses through the skin which pass up to 
the brain. TENS can help block the pain gate.  It also works by 
increasing the level of endorphins released. 
 
There are many machines on the market and it is advisable 
that you try one on loan before purchasing to see if it helps 
you. 
 
 
Examples Of Companies 
 
 Physio-Med Services, 
7-11 Glossop Brook Industrial Park, 
Glossop.   
SK13  7AJ 
Tel:  01457  860444 
 
 Body Clock Healthcare Ltd., 
108 George Lane, 
South Woodford, 
London.   
E18  1AD 
Tel:  0208  5329595 
 
 
 
 
 
 
 
 
EXERCISES 
 
The following exercises should be done 10-15 repetitions, 4 
times a day. 
 
 
1. Sit or stand with good posture. 
 
 Keeping face forward,  
tip ear towards shoulder.   
 
Hold for 10 seconds. 
 
Repeat to other side. 
 
 
 
2. Sit or stand with good posture. 
 
Turn head to one side then the other. 
 
Hold for 10 seconds. 
 
  
 
 
 
 
 
 
 
 
 
 
3. Assume upright posture with shoulders relaxed. 
 
 Move affected shoulder blade down and towards opposite hip. 
 
  
 
 
 
 
 
 
 
 
 
4. Sitting, arms crossed at shoulder height.  Turn to right. 
 
Hold for 10 seconds. 
 
Turn to left and hold. 
 
Repeat 10 times. 
 
 
 
 
 
 
 
 
 
 
 
5. Sit in a chair with pulley  
assembled as shown. 
 
Raise the affected arm  
overhead pulling down  
on the pulley with the  
other hand so that you  
feel a stretch. 
 
 
 
6. Sit in a chair with pulley assembled as shown. 
 
Raise the affected arm out to side and overhead, pulling 
down on the pulley with the other hand so that you feel a 
stretch. 
 
 
 
 
 
 
 
 
 
 
 
7.       Lie on back as shown, with affected hand at the top of the 
          stick. 
 
          Using the stick for assistance, stretch your arm higher 
          overhead. 
 
 Hold for 10 seconds. 
 
 
 
 
 
 
 
 
 
 
 
8. Stand holding stick as shown with your affected arm out  to 
the side. 
 
Using the stick for assistance, stretch your arm further out to 
side and overhead. 
 
Hold for 10 seconds. 
 
 
 
 
 
 
 
 
 
 
 
9. Stand grasping the elbow with other hand as shown. 
 
Pull the elbow and arm 
across your chest so that 
you feel a stretch. 
 
Hold for 10 seconds. 
  
 
 
 
 
 
10. Lie on your back or stand with a pillow under your arm. 
 
Using stick for assistance, rotate your operation hand and 
forearm out away from your body.  Make sure your elbow 
stays tucked into your side. 
 
Hold for 10 seconds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11. Grasp stick behind back as shown. 
  
 Slide stick up back so that you feel a stretch. 
 
 
 
 
 
 
 
 
 
 
 
12. Place a rolled hand towel under the affected arm. 
 
Grasp forearm with other hand and pull behind back and 
downwards as shown. 
  
Hold for 10 seconds. 
 
 
 
 
 
  
 
 
 
 
 
 
APPENDIX SEVEN 
 
 
 
 
 
Exercise Class recording sheet 
 
 
 
 
 
 
 
 
 
FROZEN SHOULDER STUDY 
 
Name   ………………………………………………………………………..                 Patient ID   ……………………………………… 
These exercises are aimed at improving range of movement.  Please use this sheet to record your progress. 
  
DATE:                         
1 
Pulleys 
  
Forwards 2’                         
Backwards 2’ 
2 
Flexion / Horizontal Add 
  
Over Head 2”                         
Across Body 2” 
3 
Ball Rolling 
(time) 
Forwards 2’                         
Sideways 2’ 
4 
Medial Rot/ 
Extension 
Towel + Rope 
                        
Stick behind back 
  
5 
Lateral  Rotation 
Lying with stick 
1 30
o
 
                        
2 60
o
 
                        
3 90
o
 
                        
6 
Abduction 
Stretch 
  
4 Stick 
                        
2 Doorway 
                        
7 
Scapula 
Setting 
  
1 0
o
 
                        
2 60
o
 
                        
8 Trunk rotation 
1 Chair 
                        
2 Ball 
                        
  
9 
  
  
Trunk side flx rot  
  
Ball Rolling side to side 
  
    
                      
  
10 
  
  
Proprioception/Bal 
  
  
Circular ball rolling 
                        
                 
  
 
  
 
 
 
 
 
 
APPENDIX EIGHT 
 
 
 
 
 
Standardised measurement procedure 
 
STANDARD PROCEDURE FOR MEASUREMENT OF SHOULDER  
JOINT RANGE 
 
 
 
(Taken from Norkin & White 2003) 
 
 
 
Use a 10” full circle plastic universal goniometer. 
 
 
 
□ FLEXION: 
 
 (Mean shoulder complex flexion 0-190°) 
 
• Testing position: Supine, with knees flexed to flatten the lumbar spine. 
Position the shoulder in 0° of abduction and rotation.  Place the elbow in 
extension.  Position the forearm in 0° of supination so that the palm of 
the hand faces the body. 
 
• Stabilisation: Stabilise the thorax to prevent extension of the spine and 
movement of the ribs.  The weight of the trunk may assist in stabilisation. 
 
• Testing Motion: Flex the shoulder by lifting humerus off the plinth, 
bringing hand up and over the subject’s head.   Maintain the extremity in 
neutral abduction and adduction during the motion.  The end of the ROM 
occurs when resistance to further motion is felt and attempts to 
overcome the resistance cause extension of the spine or motion of the 
ribs. 
 
• Goniometer alignment: 
 
 1. Centre the fulcrum of the goniometer over the lateral aspect of the 
 greater tubercle. 
 
 2. Align the proximal arm parallel to the midaxillary line of the thorax. 
 
3. Align the distal arm with the lateral midline of the humerus.  
Depending on how much flexion and MR occur, the lateral 
epicondyle of the humerus or the olecranon process of the ulnar 
may be helpful references. 
 
 
 
 
 
 
□ ABDUCTION: 
 
 (Mean shoulder complex abduction is 0-180°) 
 
• Testing position: Supine, with shoulder in LR and 0° of flexion and 
extension so that the palm of the hand faces anteriorly.  The elbow 
should be extended. 
 
• Stabilisation: Stabilise the thorax to prevent lateral flexion of the spine. 
The weight of the trunk may assist in stabilisation. 
 
• Testing motion: Abduct the shoulder by moving the humerus laterally 
away from the subject’s trunk.  Maintain the upper extremity in LR and 
neutral flexion and extension during the motion.  The end of the ROM 
occurs when resistance to further motion is felt and attempts to 
overcome the resistance cause lateral flexion of the spine. 
 
• Goniometer Alignment 
 
 1. Centre the fulcrum of the goniometer close to the anterior aspect 
  of the acromion process. 
 
2. Align the proximal arm so that it is parallel to the midline of the 
anterior aspect of the sternum. 
 
3. Align the distal arm with the anterior of the humerus.  Depending 
on the amount of abduction and LR that has occurred, the medial 
epicondyle may be a helpful reference. 
 
 
 
□ MEDIAL ROTATION: 
 
 (Mean shoulder complex MR is 0-90°) 
 
• Testing position: Supine, with the arm being tested in 90° of shoulder 
abduction (or as close to it as possible – document the range of 
abduction that is tested, if it’s less than 90°).  Place the forearm 
perpendicular to the supporting surface and in 0° of supination and 
pronation so that the palm of the hand faces the feet.  Rest the full length 
of the humerus on the plinth.  The elbow is not supported by the plinth.  
Place a pad under the humerus so that the humerus is level with the 
acromion process. 
• Stabilisation: Stabilisation is often needed at the distal end of the 
humerus to keep the shoulder in 90° (or maximum) abduction.  The 
thorax may be stabilised by the weight of the subject’s trunk or with the 
examiner’s hand to prevent flexion or rotation of the spine. 
 
• Testing Motion: Medially rotate the shoulder by moving the forearm 
anteriorly, bringing the palm of the hand toward the floor.  Maintain the 
shoulder in 90 degrees (or maximum) and the elbow in 90° of flexion 
during the motion.  The end of ROM occurs when resistance to further 
motion is felt and attempts to overcome the resistance cause flexion or 
rotation of the spine. 
 
• Goniometer Alignment: 
 
 1. Centre the fulcrum of the goniometer over the olecranon process. 
 
2. Align the proximal arm so that it is either perpendicular to or 
parallel with the floor. 
 
3. Align the distal arm with the ulna, using the olecranon process and 
 Ulnar styloid for reference. 
 
 
□ LATERAL ROTATION 
 
 (Mean LR of the shoulder complex is 0-90°) 
 
• Testing Position: Same as MR. 
 
• Stabilisation: Stabilisation is often needed at the distal end of the 
humerus to keep the shoulder in 90° of abduction (or its maximum if less 
than 90°). To prevent extension or rotation of the spine, the thorax may 
be stabilised by the weight of the subject’s trunk or by the examiners 
hand. 
 
• Testing Motion: Rotate the shoulder laterally by moving the forearm 
posteriorly, bringing the dorsal surface of the hand toward the floor.  
Maintain the shoulder in 90 degrees (or maximum available) of abduction 
and the elbow in 90 degrees of flexion during the motion.  The end of 
ROM occurs when resistance to further motion is felt and attempts to 
overcome the resistance cause extension or rotation of the spine. 
 
• Goniometer Alignment: 
 
 1. Centre the fulcrum of the goniometer over the olecranon process. 
 
2. Align the proximal arm so that it is either parallel to or 
perpendicular to the floor. 
 
3. Align the distal arm with the ulnar, using the olecranon process 
and the ulnar styloid for reference. 
 
 
 
 
